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Human Suppressor of RNA polymerase B (hSRB7) /Med21 is a component of the 
mammalian Mediator complex, and this subunit has been shown to interact directly with 
human S-phase kinase associated protein 1 (hSkp1). The latter is a component of the 
hSkp1-Cul1-F-box protein (SCF) complex, an E3 ubiquitin ligase involved in the process 
of ubiquitylation of target proteins.  
In this study, the protein-protein interaction between hSkp1p and hSrb7p was 
shown using the yeast-split ubiquitin system and mammalian split-ubiquitin system, 
respectively. As it is speculated that hSkp1p may be recruited to the holoenzyme by its 
interaction with hSrb7p, the biological relevance of this interaction and the role of 
hSkp1p in transcription were examined. Small-interfering RNA was used to reduce 
hSkp1 transcripts in HeLa cells. This was coupled to reverse-transcription polymerase 
chain reaction (RT-PCR) to study the efficiency of the induction of Hsp70B’ mRNA and 
to examine the effects of hSkp1 on activated transcription. The results indicated that 
hSkp1p is necessary for the full activated transcription of Hsp70B’ by heat-shock. Future 
experiments would include chromatin-immunoprecipitation assay (Ch-IP) to show that 
hSkp1p is indeed recruited to the heat-shock promoter region together with hSrb7p. 
In the last part of this project, the yeast split-ubiquitin system, a protein-protein 
interaction assay that is based upon a fragment complementation coupled to a conditional 
proteolysis strategy, was used to isolate interacting partners of hSkp1p in hope of 
detecting novel roles of hSkp1p in cellular processes. Complementary DNA (cDNA) 
isolated from HeLa cells were fused to the N-terminus of ubiquitin (Nub-cDNA) in order 
to create a cDNA library for screening of interacting proteins in S. cerevisiae. The bait 
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 vii
was hSkp1p fused to the C-terminal half of ubiquitin (Cub) followed by orotidine-5’-
phosphate decarboxylase (Ura3) that had been modified such that the first amino acid 
was replaced by an arginine residue (RUra3), resulting in the fusion protein hSkp1-Cub-
RUra3. Cyclin-dependent kinase (Cdk) 2-interacting protein (CINP) was isolated in the 
screen; this protein is associated with active cyclin E/Cdk2 and cyclin A/Cdk2 
complexes, and has been suggested to be involved in DNA replication. Therefore this 
could indicate that hSkp1p may play a role in DNA replication. 
 This study has provided evidence of hSkp1p in transcription, and strengthened the 
link between ubiquitin-proteasome pathway and transcriptional regulation. Future work 
on finding new interacting partners of hSkp1p and characterizing their interaction would 
allow us to understand the various cellular processes that hSkp1p, and possibly the 
ubiquitin-proteasome pathway, may be involved in. 
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51. Introduction 
 The Mediator complex is involved in transcriptional regulation, transducing 
signals from activators and repressors to RNA polymerase II (Myers and Kornberg, 
2000). It was first discovered in Saccharomyces cerevisiae as an activity that could 
mediate and integrate the signals of transcriptional activators to the basal RNA 
polymerase machinery, and was therefore termed Mediator (Kelleher et al. 1990). 
Subsequently, biochemical and structural studies in various laboratories revealed a 
number of mammalian Mediator complexes like the thyroid receptor associated proteins 
(TRAP) (Fondell et al., 1996), SRB/MED-containing cofactor complex (SMCC) (Gu et 
al., 1999). Today, it is established that the mammalian Mediator complex is made up of 
at least 30 subunits (Sato et al. 2004), although it should be noted that some subunits are 
missing in some purifications performed. This may be due to the different techniques 
used that gave rise to the discrepancies, or because there are different Mediator entities in 
the cells, each with different functions (Myers and Kornberg, 2000; Näär et al., 2001 and 
Sato et al., 2004). 
One subunit found in both budding yeast and mammalian Mediator complex is the 
Suppressor of RNA polymerase B (SRB7) / MED21. This is an essential gene in yeast, 
and it was identified in a suppressor screen for mutants that restore the viability of cells 
with truncations in RNA polymerase II CTD (Hengartner et al., 1995). Later on, it was 
shown that ySrb7p interacted with repressor yTup1p both in vitro and in vivo (Gromöller 
and Lehming, 2000). The proposed model was that yMed6p, another subunit in the 
Mediator complex, and yTup1p both compete for binding to ySrb7p; collectively, this 
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indicated a direct effect of yTup1p mediated repression on the holoenzyme. SRB7 is an 
essential gene for the very early stages of embryogenesis in mouse (Tudor et al., 1999). 
Using the yeast split-ubiquitin system in S. cerevisiae, Debra Morley discovered 
that hSrb7p interacts with hSkp1p (PhD Thesis dissertation, Liverpool John Moores 
University, 2003). The yeast split-ubiquitin system is based on the conditional 
degradation design (Wittke et al., 1999). The reporter protein used was orotidine-5’-
phosphate decarboxylase (Ura3) that had been modified such that the first amino acid 
was now an arginine residue (RUra3). One protein was fused to the N-terminus of 
ubiquitin (Nub) and the second protein was fused to the C-terminus of ubiquitin (Cub) that 
was extended by the RUra3 protein (Cub-RUra3). According to the N-end rule, which 
states that the N-terminal amino acid mediates the in vivo half-life of a protein 
(Varshavsky, 1996), arginine is a destablishing residue in S. cerevisiae. A really-
interesting-new-gene (RING) finger-containing E3 ubiquitin ligase, Ubr1p, recognizes 
the N-terminal residues and adds a chain of multi-ubiquitin to the internal lysine residue 
of the substrate (Dohmen et al., 1991). Subsequently, the poly-ubiquitylated substrate is 
degraded by the 26S proteasome. If the two proteins interact in the cell, the two halves of 
ubiquitin would be in close proximity and a native-like ubiquitin moiety would be 
formed. This would cause the release of the reporter protein by ubiquitin-specific 
proteases (Ubps), and its degradation by the enzymes of the N-end rule. As a result, the 
reporter protein RUra3 was degraded and the phenotype of the yeast cells became uracil-
deficient. Such protein-protein interactions were detected by the use of media containing 
5-fluoroorotic acid (5-FOA), a drug which counterselects the Ura3 enzymatic activity. 
Using this protein-protein interaction assay and hSrb7-Cub-RUra3 as bait, Debra Morley 
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had isolated a C-terminal portion of hSkp1p fused downstream of Nub using a Nub-cDNA 
fusion library. The interaction between hSkp1p and hSrb7p was also observed in the 
human cells using the mammalian split-ubiquitin system. This assay is similar to the 
yeast-split ubiquitin in that it is also a fragment complementation assay based on a 
conditional proteolysis strategy, but the reporter gene used differs from the yeast system. 
Rojo-Niersbach et al. (2000) had shown the use of an RGpt2 reporter protein in selection 
of protein interactions in the human fibroblast cell line HT1080HPRT- (Pellegrini et al., 
1989). This cell line lacks the enzyme hypoxanthine-guanine phosphoribosyltransferase 
(HPRT), and it is therefore sensitive to medium containing 
hypoxanthine/aminopterin/thymine (HAT), but is resistant to medium containing 6-
thioguanine (6-TG). The guanine phosphoryltransferase 2 (gpt2) gene of Escherichia coli 
is able to complement the HPRT- deficiency. Should hSkp1p and hSrb7p interact in vivo, 
the two proteins would be brought in close proximities. This resulted in the reconstitution 
of ubiquitin, and Ubps would cleave the hSrb7-Cub-RGpt2 fusion, and the RGpt2 reporter 
protein would be rapidly degraded by the enzymes of the N-end rule. Therefore cells that 
had co-expressed the interacting protein pair hSrb7-Cub-RGpt2 and Nub-hSkp1 would be 
HAT sensitive and 6-TG resistant. In addition, Debra Morley had shown that the 
interaction was a direct one by performing pull-down with glutathione-S-transferase 
(GST)-tagged proteins.  
 S-phase kinase protein 1 (Skp1) had been discovered due to its association with 
cyclinA-Cdk2 complex (Zhang et al., 1995). However it was later established by Bai et 
al. (1996) that Skp1p does not interact directly with cyclinA-Cdk2 complex but through 
another protein, the S-phase kinase associated protein (Skp2). In Saccharomyces 
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cerevisiae, Skp1p was found in a protein-protein interaction screen for interacting 
partners of cyclin F, and protein analysis of cyclin F revealed it had a novel motif (Bai et 
al., 1996). This motif was termed the F-box domain, and the family of F-box proteins 
was born. A year later, the E3 ubiquitin ligase complex responsible for ubiquitylation of 
target proteins was discovered, and this complex was termed ‘Skp1-Cullin1-F-box 
protein’ or SCF (Skowyra et al., 1997 and Feldman et al., 1997). This complex is part of 
the ubiquitin-proteasome pathway, another important pathway in the cell to ensure the 
turn-over of proteins by degrading them when they are no longer necessary. It starts with 
the process of ubiquitylation, defined as the covalent attachment of ubiquitin to the target 
protein (Welchman et al., 2005). Essentially, an isopeptide bond is formed between a ε-
amino group of a lysyl residue in a target protein and the C-terminal glycine of ubiquitin. 
Three sets of enzymes are needed for ubiquitylation, and they are the ubiquitin-activating 
(E1), ubiquitin-conjugating (E2) and the ubiquitin ligase (E3). The conjugation of a chain 
of ubiquitin marks the substrate protein to be degraded by the 26S proteasome, an ATP-
dependent multisubunit protease (Welchman et al., 2005). In the SCF complex, the F-box 
protein is the variable component in the complex, and some 67 proteins that have contain 
the F-box sequence motif had been discovered to date (Jin et al., 2004). Interestingly, 
Skp1p has been found to interact with several proteins that do not contain the F-box 
motif. For instance, the interaction of ySkp1p with Ctf13p and Sgt1p in yeast is important 
for the formation of kinetochore complex, CBF3 (Kaplan et al., 1997 and Rodrigo-Brenni 
et al., 2004). ySkp1p is also known to interact with Rav1p and Rav2p, and together these 
proteins form a complex known as ‘regulator of the H+ ATPase of the vacuolar and 
endosomal membranes’ (RAVE) (Seol et al., 2001). 
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 Incidentally, SKP1 was found to have significant homology to eukaryotic 
transcription factor Transcription Elongation Factor B (TCEB1) (Sowden et al. 1995), 
and TCEB1 is now more commonly known as ElonginC, a subunit of the transcription 
factor SIII elongation complex (Bradsher et al., 1993a,b). This complex had been isolated 
as a stimulatory factor of RNA polymerase II during elongation by stimulating the rate of 
transcription, although the exact mechanisms have not been determined to date (Sims et 
al., 2004). In addition, ElonginC is able to form a complex with ElonginB, Cul2p and the 
RING-protein Hrt1p to form a multiple subunit E3 ubiquitin ligase (Lonergan et al., 1998 
and Iwai et al., 1999). The ElonginBC-Cul2p E3 ligase binds to various proteins that 
carry the BC-box motifs like von Hippel-Lindau (VHL) tumor suppressor (Wykoff et al., 
2001), and such BC-box proteins are similar to the F-box proteins in the SCF complexes 
in that they act as an adapter between the substrate and the ubiquitin ligase. Interestingly, 
Brower et al. (2002) had shown that the Elongin BC-Cul2p complex is able to bind to 
Med8p, a component of the Mediator complex, and reconstitute ubiquitin ligase activity 
was detected.   
 Given the interactions of hMed8p and hSrb7p with hElonginC and hSkp1p 
respectively (Figure 1), one may speculate that the ubiquitin ligase activity is recruited to 
the holoenzyme or the Mediator complex at the promoter region. This could be the link 
between ubiquitin-proteasome pathway and transcription. According to the model by 
Muratani and Tansey (2003), ubiquitin ligase could be recruited to the site of 
transcription and ubiquitylate many factors like the activators, histones or even the RNA 
polymerase II. These target proteins, like the activator, would then be degraded by the 
26S proteasome, thereby promoting transcriptional elongation. However, more data is 
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Figure 1: Schematic representation of the interactions between Mediator subunits hSrb7p 
and Med8p with Skp1p and ElonginC.  
The Mediator complex (represented in grey) is divided into three structural domains, the head, 
middle and tail domains; hSrb7p (shown in blue) is believed to be in the middle domain, whereas 
hMed8p (shown in red) is proposed to be in the head domain. hSkp1p is associated with the E3 
ubiquitin ligase SCF complex, whereas Elongin C is part of the E3 ubiquitin ligase Elongin BC 
complex. The arrows indicate the protein-protein interactions.  
 
 Skp1p may have a much wider role than just as an adapter protein in the SCF E3 
ubiquitin ligase, given the fact that it can bind to proteins that do not have an F-box 
motif, and that it is homologous to Elongin C. In the first part of this study, the yeast-
split-ubiquitin system and the mammalian ubiquitin system was used to verify that full-
length hSkp1p and hSrb7p indeed interact in S. cerevisiae and human cells respectively. 
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examine the biological relevance of the interaction. It is plausible that hSkp1p is recruited 
to the holoenzyme by hSrb7p, and therefore the next step would be to understand the 
effects of hSkp1p on transcription. To do this, RNA interference was employed to reduce 
hSkp1 transcripts in HeLa cells, and the effects of this reduction was examined on the 
heat-shock gene transcription using reverse-transcription polymerase chain reaction (RT-
PCR). If hSkp1p played an important role in transcription, for instance, in transcriptional 
activation, the knock-down of hSkp1 would reduce the activated Hsp70B’ transcripts. In 
addition, protein-protein interaction assay to search for interacting partners of hSkp1p 
may give us a better understanding of the functions of hSkp1p. Thus the second aim of 
this project was to use the yeast split-ubiquitin system to screen for interacting partners of 
hSkp1p fused to  C-terminus of ubiquitin (Cub) followed by the Ura3 enzyme that had 
been modified to begin with an arginine residue (hSkp1-Cub-RUra3). Complementary 
DNA (cDNA) isolated from HeLa cells were fused to N-terminus of ubiquitin (Nub-
cDNA), thereby creating a cDNA library which was used to screen for interacting 
partners of hSkp1p.  
 This study provides an insight into the biological relevance of the protein-protein 
interaction between hSkp1p and hSrb7p, and allows one to examine the role of hSkp1p in 
transcription. These results may provide evidence to strengthen the link between 
ubiquitin-proteasome pathways and transcription regulation, and new regulatory 
strategies of transcription involving the ubiquitin-proteasome pathway may be uncovered 
to allow us to understand the underlying mechanisms of transcriptional regulation. 
Furthermore, the characterization of proteins that interact with hSkp1p may help us 
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discover the cellular processes that hSkp1p, and possibly the ubiquitin-proteasome 
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2. SURVEY OF LITERATURE 
 
2.1 Transcription of eukaryotic protein-coding genes 
 Eukaryotes have many genes along their chromosome, and many studies have 
been done to elucidate how these genes are expressed and regulated. It was discovered 
that the purified RNA polymerase were insufficient in initiating transcription in vitro 
(Sentenac, 1985). Thus it was clear that additional factors were necessary for selective 
transcription initiation. Following this, general transcription factors (GTFs) were 
identified through fractionation of cell extracts (Zawel and Reinberg, 1992; Conaway 
and Conaway, 1993). These factors permit efficient selective initiation by RNA 
polymerase II (RNAPII). The set of basal or GTFs required for specific promoter 
binding by RNA polymerase II in vitro includes TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
TFIIH.  
 A second class of transcription factors that was identified are the activator 
proteins that are capable of binding to DNA sequences either upstream or downstream 
of the promoters. These activators are able to stimulate the initiation of transcription, 
and so it was thought that these eukaryotic proteins were like their prokaryotic 
counterparts in that these proteins would exert their effect directly through the 
transcription machinery (Myers and Kornberg, 2000). This was proven otherwise with 
the discovery of a third class of transcription factors: the transcriptional coactivator 
complexes (Bjorklund et al., 1999; Näär et al., 2001). These proteins act as adaptors 
between activators (or repressors) and the transcription machinery, and two main groups 
of such regulators can be differentiated. One group affects the chromatin template, and 
the other group consists of regulators that require RNA polymerase II and its associated 
  Survey of Literature 
 10
proteins to function. The first group includes chromatin modifying complexes, histone 
acetyltransferase complexes and histone deacetylase complexes. The second group is 
made up of TBP-associated factors (TAFs), universal stimulatory activity (USA) and 
Mediator complexes. The latter will be discussed below. 
 
2.1.1 Discovery of the Mediator complex 
 The observation of how one transcriptional activator may interfere with the 
effects of another in yeast (Gill and Ptashne, 1988) was one of the first indirect evidence 
for the presence of an activity which acts as a common target for transcriptional 
activators. This phenomenon of activator interference was termed squelching. At that 
time, it was thought that the general transcription factors like TFIIB and RNA 
polymerase II may be the source of this interference as Brandl et al. (1989) and Stringer 
et al. (1990) have shown that these proteins bind to activator proteins. However, the 
work done by Kelleher et al. (1990) proved otherwise. When activator interference was 
reproduced in vitro, the addition of RNA polymerase II or the various general 
transcription factors in excess amounts did not reverse the interference. This suggested 
that the target of the activators is distinct from the basal transcriptional machinery. 
Instead, it was the addition of a partially purified yeast component that lifted the 
interference. The activity in this component was believed to mediate and integrate the 
signals of transcriptional activators on the basal RNA polymerase machinery, and was 
termed Mediator. Further studies carried out by Flanagan et al. (1991) presented a direct 
evidence for a mediator that caused the in vitro stimulation of transcription by activators 
Gal4-VP16 and Gcn4. 
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 The other concurrent line of work was in the analysis of yeast genetics, and was 
initially unrelated. In the screen for suppressors of partial truncations in the C-terminal 
domain (CTD) of the large subunit of RNAPII, a suppressor of RNA polymerase B 
(SRB) protein termed Srb2 (Med20) was isolated as extragenic suppressors of the cold-
sensitive phenotype of CTD domain deletion mutants (Nonet and Young, 1989). 
Subsequent work by Thompson et al. (1993) lead to the identification of three other 
SRB proteins – Srb4 (Med17), Srb5 (Med18) and Srb6 (Med22), and it was shown that 
these four SRB proteins are components of a multisubunit complex that can bind to 
recombinant CTD protein. It was the purification of the Mediator activity that 
converged the two lines of work together. The Mediator was shown to be made up of 
some 20 polypeptides, and a holoenzyme form of RNAPII, which consisted of the 
mediator associated with core 12-subunit of the polymerase was isolated (Kim et al., 
1994; Koleske and Young, 1994).  
The existence of the Mediator complex in higher eukaryotes was not 
immediately found, and it was thought that there was no conservation of the complex 
during the evolution of the higher organisms. Subsequently, biochemical and structural 
studies in the various labs revealed a number of mammalian Mediator complexes; the 
list includes thyroid receptor associated proteins (TRAP) (Fondell et al., 1996), 
SRB/MED-containing cofactor complex (SMCC) (Gu et al., 1999), a vitamin D 
receptor (VDR)-interacting  complex (DRIP) (Rachez et al., 1999), an SREBP-
interacting complex (ARC) (Näär et al., 1998), an E1A-interacting complex (human 
Mediator) (Boyer et al., 1999), the upstream stimulatory activity (USA)- derived 
positive cofactor 2 (PC2) (Malik et al., 2000) and cofactor required for Sp1 (CRSP) 
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complex (Ryu et al., 1999), the negative regulator of activated transcription (NAT) (Sun 
et al., 1998), and the mouse Mediator complexes (Jiang et al., 1998). The basis for the 
isolation of these complexes can be divided into three groups. In the first group, these 
complexes were isolated on their ability to interact with specific activators. For DRIP, it 
was through ligand-bound vitamin-D receptor, ARC through sterol-response-element-
binding protein (SREBP) and VP16, TRAP complex through its association with 
ligand-bound thyroid-hormone receptor, and human Mediator through E1A. As for the 
second group, the isolation had been based on homology of specific subunits to the 
yeast Mediator polypeptides. SMCC, NAT and the murine mediator fall into this group. 
PC2 and CRSP make up the third group which was isolated on the basis of its 
coactivator activities; CRSP as a coactivator for Sp1 (Ryu et al., 1999), and PC2 for 
several activators like Sp1 and GAL4-based activators (Kretzschmar et al., 1994).  
The proteins that make up the mammalian Mediator are not as defined as the 
yeast Mediator. For instance, the mammalian Mediator subunits like TRAP220 
(MED1), Rgr1 (MED14), TRAP80 (MED17), TRAP36 (MED4), MED6, MED7, and 
Srb7 (MED21), are consistently found in nearly all Mediator purifications. However, 
for other Mediator proteins like the TRAP25 (MED30), MED8, CRSP70 (MED26), and 
ARC92 (MED25), these have been identified in only a few preparations (Sato et al., 
2004). This could be due to the different purification techniques used; some techniques 
may not be sufficiently sensitive or that there were protein loss during the purifications. 
A more intriguing explanation would be that the differences could be due to the 
different entities of the Mediator complexes under various conditions, an indicator of 
the different functions the complex has (Conaway et al., 2005). In a bid to define the 
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subunit composition of the mammalian Mediator, Sato et al. (2004) used the 
multidimensional protein identification technology (MudPIT) approach. A total of six 
different Mediator subunits were FLAG-tagged for the isolation of their associated 
proteins, and all 30 of the subunits previously identified as subunits of mammalian 
Mediator-like complexes were isolated. Additional proteins that were isolated with the 
epitope tagged subunits were the alternative forms of the kinase module subunits Srb8 
(Med12), Srb9 (Med13) and CDK8. A unified nomenclature for the subunits of the 
Mediator complexes has recently been suggested to facilitate in cross-species 
comparisons (Bourbon et al., 2004). 
 
2.1.2 Role of Mediator in transcription 
 The Mediator complex is known to interact with the CTD of the RNA 
polymerase II, specifically with the unphosphorylated form of CTD (Myers et al., 
1998). The unphosphorylated form of the polymerase II is known to be an indication of 
promoter-bound initiation complex, whereas the phosphorylated form is an indication of 
RNAPII engaging in active elongation. It has been assumed that the role of Mediator is 
to nucleate preinitiation complex (PIC) consisting of the RNAPII and GTFs to form an 
active transcribing complex. Interestingly, Takagi et al. (2005) reported that the most 
abundant form of the Mediator is its free form, and not as a holoenzyme complex. This 
has implications that the Mediator and the RNAPII are recruited independently to the 
promoter region to form the PIC. The finding is supported by several works like that of 
Park et al. (2001) where instead of the holoenzyme, the Mediator is rapidly recruited to 
the heat shock promoter by heat shock factor (HSF) upon heat shock in Drosophila 
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melanogaster. Therefore, the model proposed for transcription regulation by the 
Mediator dictates that a DNA-binding activator brings the Mediator to the promoter, 
and a “scaffold platform”, which includes GTFs like the TFIIB and TFIID, is 
established for the recruitment of RNAPII. As RNAPII escapes the promoter clearance 
and moves on to the elongation stage, the platform remains at the promoter to enable the 
rapid assembly of a new round of transcription known as reinitiation (Yudkovsky et al., 
2000; Chadick and Asturias, 2005). 
 Specific interactions have been demonstrated between DNA-binding 
transcriptional activators and subunits of the Mediator via the transcriptional activation 
domains (TADs) of the former. For instance, the mammalian Rgr1 (Med14) interacts 
with activator STAT2 and therefore indicates that the Mediator is involved in interferon 
activated gene regulation (Lau et al., 2003). In addition, Trap100 (Med23) is able to 
bind to activators like the adenovirus E1A protein (Boyer et al., 1999), and Med25 can 
bind to the TAD of VP16 (Mittler et al., 2003). Therefore, these interactions strongly 
suggest that the Mediator activates transcription and is recruited to the promoter region 
for the formation of the pre-initiation complex. The role of Mediator in transcription 
repression has also been reported, especially for the Srb8-11 module (Song et al., 1998; 
Lee et al., 2000 and Kim et al., 2004) 
 There are also a few enzymatic activities associated with the Mediator complex 
known to date. Lorch et al. (2000) showed that purified Mediator has histone 
acetyltransferase (HAT) activity, and has direct interactions with free nucleosomes. 
This HAT activity has been attributed to the Nut 1 subunit. However, as NUT1 is a non-
essential gene in yeast, it is believed that the HAT activity would not be a major role in 
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function of the Mediator. Kinase activity has also been associated with the Mediator 
complex, especially for subunits Cdk8-CyclinC. In S. cerevisiae, this kinase has been 
shown to be the enzyme responsible for the phosphorylation of transcriptional activator 
Gcn4, and this modified form of Gcn4 was subsequently poly-ubiquitylated and 
degraded (Chi et al., 2001). The cyclin H subunit of TFIIH is another target of cdk8-
cyclinC; the phosphorylation of cyclin H results in the repression of TFIIH CTD kinase, 
therefore repressing the role of TFIIH in transcription (Akoulitchev et al., 2000). There 
were also suggestions that an ubiquitin ligase activity could be recruited to the Mediator 
complex as seen for the Med8p subunit interacting with Elongin BC proteins (Brower et 
al., 2002). The group had shown that together with ubiquitin ligase components Cul2p, 
Rbx1p, Elongin B and Elongin C, Med8p was able to reconstitute an E3 ubiquitin 
ligase. 
 
2.1.3 Structure of the Mediator complex 
 Purification of the yeast Mediator complex showed that it was a large complex 
of approximately 1MDa, and single particle electron microscopy (EM) was employed 
for characterization of the structure of the complex. Isolated Mediator in its free form 
has been observed to be a compact structure. Upon incubation with the polymerase, the 
Mediator undergoes conformational changes and becomes an extended structure, with 
three distinctive Mediator domains that envelope the globular polymerase. These 
domains are characterized as head (h), middle (m), and tail (t) (Asturias et al., 1999; 
Dotson et al., 2000). According to the proposed locations of the core Mediator modules, 
the tail region is believed to correspond to the Gal11 module, the Med9/10 module to 
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Figure 2. Structural organization of the S. cerevisiae core Mediator associated with 
RNA polymerase II. Reprinted from Cell, 110(2), Boube et al., Evidence for a mediator 
of RNA polymerase II transcription regulation conserved from yeast to man, 143-51; 
Copyright (2002) with permission from Elsevier. 
The figure shows the proposed locations of core Mediator modules and a model for subunit 
organization based on genetic, biochemical, and two-hybrid interactions (Boube et al., 2002; Ito 
et al., 2001). Underlined subunits are essential for viability. 
 
 
2.1.4 Suppressor of RNA polymerase B (SRB7) / Med21 
This is an essential yeast gene, and the identification of this gene was through a 
screen for a recessive mutation that restores the viability of mutants with truncations in 
RNA polymerase II CTD (Hengartner et al., 1995). Chao et al. (1996) identified 
sequences similar to yeast Srb7 through EST databases, and the predicted 144-amino 
acid human protein is 35% identical to the yeast Srb7 protein. Mouse knockout studies 
have shown that the SRB7 subunit of TRAP/SMCC is essential for the very early stage 
of embryogenesis (Tudor et al., 1999). Gromöller and Lehming (2000) showed that 
yeast Srb7p interacted with repressor Tup1p both in vitro and in vivo. The model 
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proposed was that Med6p, another subunit in the Mediator complex, and Tup1p both 
compete for binding to Srb7p; collectively, this indicated a direct effect of Tup1p 
mediated repression on the holoenzyme. 
 
Section 2.2 Insight into Skp1 and the SCF ligase 
2.2.1 Ubiquitin and the process of ubiquitylation 
 Ubiquitin is a small protein of 76 amino acids, and yet when multiple moieties 
are covalently attached to a target protein, this modification can lead to the degradation 
of that protein via the 26S proteasome. Hence ubiquitin has earned its name as the 
“kiss-of-death” protein. The investigations into the chemistries and the functions of 
protein degradation have lead to three scientists, Avram Hershko, Aaron Ciechanover, 
and Irwin Rose, receiving the Nobel Prize in Chemistry in 2004 (Giles, 2004). Today, 
much more information is available about ubiquitin since its discovery in 1980 as an 
ATP-dependent proteolysis factor (Wilkinson et al., 1980); recent findings also indicate 
that the modification of proteins with ubiquitin has a wider role than simply a 
degradation signal. 
 Ubiquitin is absent in prokaryotes, but some homologues of the E1 ubiquitin-
activating enzymes have been discovered (Welchman et al., 2005). Ubiquitylation is 
defined as the covalent attachment of ubiquitin to the target protein. Essentially, an 
isopeptide bond is formed between a ε-amino group of a lysyl residue in a target protein 
and the C-terminal glycine of ubiquitin. Three sets of enzymes are needed for 
ubiquitylation, and they are the ubiquitin-activating (E1), ubiquitin-conjugating (E2) 
and the ubiquitin ligase (E3). This pathway is summarized in Figure 3.  
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 Two different classes of modification with ubiquitin can occur: 
monoubiquitylation and polyubiquitylation. Monoubiquitylation, as its name implies, 
involves the transfer of only a single ubiquitin residue onto a lysine or several lysines of 
the substrate protein. This form of modification is now known to regulate the 
localization and activity of the target protein; the three main cellular processes that 
monoubiquitylation is involved in are the regulation of histones, endocytosis (Dupre et 
al., 2004), and budding of retrovirus (Hicke, 2001). Although monoubiquitylation is the 
first step to polyubiquitylation, the conjugation of a single ubiquitin molecule to the 
protein does not result in its degradation. As for polyubiquitylation, several ubiquitins 
are added to a single lysine residue of the target protein. This chain of ubiquitin is 
usually formed through the isopeptide bond between the C-terminal glycine of ubiquitin 
and the lysine 48 residue of the ubiquitin formerly added to the chain. The presence of 
four or more ubiquitins in a chain on a target protein is the indication for proteolysis via 
the 26S proteasome pathway.  
 
2.2.2 E3 ligases 
 There are three families of E3 ligases: the homologous-to-the-carboxyl-
terminus-of-E6-AP (HECT) family, the really-interesting-novel-gene (RING) family 
and the recently discovered U-box protein family (Hatakeyama and Nakayama, 2003). 
The RING-type E3 ligase can be categorized into two groups: they are either made up 
of a single subunit or multiple subunit complexes. Essentially, the various RING-type 
E3 ligase can be subcategorized into four other groups: the Skp1-Cul1-F-box protein 
(SCF), the anaphase-promoting complex/cyclosome (APC/C), the Cul2-ElonginB-
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ElonginC complex and the single polypeptide RING-finger E3s (Hatakeyama and 
Nakayama, 2003).  
 The SCF ligase is made up of three invariable components: Skp1p, Cullin1p and 
Hrt1p/Rbx1p. F-box proteins (FBPs), which bind to Skp1p, are the variable components 
in the ligase. In the SCF complex, only Cullin1p that associates with the RING-finger 
protein Hrt1p, although there are six CUL genes identified in humans (Kipreos et al., 
1996). Skp1p acts as an adaptor, linking Hrt1p and Cullin1p to the various F-box 
proteins. One well-characterized human F-box protein is that of Skp2p, and thus the E3 
ligase is termed SCFSkp2 where the superscript denotes the F-box protein. The structure 
of the SCFSkp2 quaternary complex is shown in Figure 5.  
 The N-terminal helical region of Cul1p is made up of three repeats of a novel 
structural domain called the cullin repeat. Essentially the cullin repeat is made up of 
five helices which are labeled A to E in Figure 4. In Cul1p, it is the first cullin repeat 
that comes into contact with Skp1p, whereas the C-terminus domain binds to 
Rbx1p/Hrt1p (Zheng et al., 2002). Interestingly, Cul1p can be modified by the 
conjugation of ubiquitin-like small molecule Nedd8, and neddylation of Cul1p has been 
observed to enhance the activities of SCFSkp2 and SCFβ-TrCP (Ohh et al., 2002 and Amir 
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Figure 3: Ubiquitin conjugation and the ubiquitin–proteasome system.  
Reproduced with permissions from Nature Reviews Molecular Cell Biology Welchman et 
al., Ubiquitin and ubiquitin-like proteins as multifunctional signals, Nature Rev. Mol. Cell 
Biol 6 (8) 599-609, 2005; and Ciechanover, A. Proteolysis: from the lysosome to ubiquitin 
and the proteasome. Nature Rev. Mol. Cell Biol. 6, 79-87, 2005; copyright (2005) 
Macmillan Magazines Ltd 
Ubiquitin is activated by the ubiquitin-activating enzyme (E1; step 1), and is subsequently 
transferred to an ubiquitin-conjugating enzyme (E2; step 2). In most cases, the E2 enzyme and 
the protein substrate both bind specifically to a particular ubiquitin-protein ligase (E3), and the 
activated ubiquitin moiety is then transferred to the protein substrate (step 3). The successive 
conjugation of ubiquitin moieties generates a polyubiquitin chain that functions as a signal to 
target the protein substrate to the 26S proteasome for degradation (step 4). The substrate is 
degraded to short peptides (step 5), and reusable ubiquitin is released by deubiquitylating 
enzymes (DUBs; step 6). Pi, inorganic phosphate; PPi, pyrophosphate; Ub, ubiquitin.   
 
 
          
 
Figure 4: Overall structure of the Cul1-Rbx1/Hrt1-Skp1-F-boxSkp2 quaternary complex. 
Reprinted by permission from Macmillan Publishers Ltd: Nature, Structure of the Cul1-
Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex, Zheng et al. 416(6882): 703-9, 
copyright (2002). 
Cul1, Rbx1/Hrt1, Skp1 and the F-box of Skp2 are colored in green, red, blue and magenta 
respectively. The five helices that make up the cullin-repeat motif are labeled for the second 
repeat. Figures were prepared with the programs MOLSCRIPT. GL_RENDER and POVRAY.  
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 The SCF ligase is similar to another E3 ligase, the Cul2-ElonginBC complex 
(Lonergan et al., 1998 and Iwai et al., 1999). This family of E3 ligase consists of 
several proteins: Cul2p, RING protein Rbx1p/Hrt1p, ElonginB, ElonginC and a 
substrate recognition protein which contains a 10 amino acid degenerate sequence motif 
known as the BC-box. The substrate recognition protein acts as a linker between the 
substrate to be degraded and Cul2-ElonginBC; it is therefore functionally similar to the 
F-box protein in the SCF complex. This substrate recognition protein is the variable 
subunit in the E3 ligase, and examples of such proteins are the suppressor of cytokine 
signaling (SOCS)-box protein, ElonginA and the von Hippel-Lindau (VHL) tumor 
suppressor. The VHL protein was observed to be mutated in patients with the von 
Hippel-Lindau disease, and this results in the accumulation of the hypoxia-regulated 
transcription factor HIF1α. In turn, the increase in HIFα leads to transcription of 
hypoxia-inducible genes, thereby promoting tumor growth (Wykoff et al., 2001). A 
comparison of the SCFSkp2 and VHL-ElonginC-ElonginB complexes was done by 
Schulman et al. (2000). The ElonginC structure was noted to be similar to the N-
terminal two-thirds of Skp1p, but it is missing the three helical domains which allows 
Skp1p to interact with Skp2p (Schulman et al., 2000). Thus Skp1p and ElonginC bind 
their substrate recognition partners differently. In addition, Yan et al. (2004) 
investigated the sequences in Skp1 and ElonginC that determine the binding to their 
cullin partners as Skp1p is known to bind to Cul1p whereas ElonginC binds to Cul2p. 
Short 11 amino acid structural elements in Skp1p and ElonginC were identified to be 
responsible for the selectivity in binding to different Cullins. 
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 Interestingly, a novel interaction between ElonginC and mMed8p of the 
Mediator complex was discovered when a protein-protein interaction screen was carried 
out by Brower et al. (2002). A yeast-two hybrid screen using cDNA from human B-cell 
with ElonginC as bait revealed a mammalian BC-box protein that had homology to the 
S. cerevisiae Med8p. This BC-box sequence motif present in Med8p was the same as 
the domain present in the other substrate recognition proteins of ElonginBC-Cul2 E3 
ligase like the VHL protein and ElonginA. In addition, Brower et al. (2002) also 
showed that the mammalian Med8p, Rbx1p/Hrt1p, Cul2p, ElonginB and ElonginC can 
reconstitute ubiquitin ligase activity, and that the mammalian Med8p can be copurified 
with other Mediator subunits.   
 
2.2.3 S-Phase Kinase-Associated Protein 1A (Skp1) 
 There are several alternative titles to S-Phase Kinase-Associated Protein 1A 
(Skp1A), but presently, this is its most commonly used name. The other titles are the 
Cdk2/Cyclin A-Associated Protein, p19A, Organ of Corti Protein 2 (OCP2) and 
Transcription Elongation Factor B, 1-Like, (TCEB1L), and were related to how the 
SKP1A gene was discovered. In 1995, Chen et al. described the cloning of Ocp2 gene 
encoding OCP-II from a guinea pig organ-of-Corti cDNA library. Their results 
indicated that OCP2 had specialized roles in transcription in the inner ear. In the same 
year, there were two other reports of the same gene, but the link between them was not 
established then. Sowden et al. (1995) isolated a cDNA from human embryo libraries in 
a bid to find transcription factors that aid RNA polymerase II in the elongation phase. 
The cDNA was found termed Transcription Elongation Factor B, 1-Like (TCEB1L) as 
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it had significant homology to eukaryotic transcription factor Transcription Elongation 
Factor B (TCEB1). The latter is a subunit of the transcription factor SIII elongation 
complex. As for Zhang et al. (1995), it was the discovery of a protein of 19kDa 
associated with cyclinA-Cdk2 complex. As amino acid comparisons with databases did 
not yield any results, this 19kDa protein was termed S-Phase Kinase-Associated Protein 
1 since it associates with the cyclinA-Cdk2 complex primarily during the S-phase of the 
cell cycle.  In the end, it was the journal by Liang et al. (1997) that linked the three 
genes together in a bid to map the physical location of the gene. It should be noted that 
although Skp1p is not in direct interaction with cyclinA-Cdk2 complex; it requires 
another protein S-phase kinase associated protein 2 (Skp2) (Yam et al., 1999). 
  
2.2.3.1 Functions of Skp1p in the SCF ligase complex 
 Bai et al. (1996) isolated SKP1 twice in separate screens in S. cerevisiae; it was 
originally isolated in a screen for suppressors of CDC34, an E2 ubiquitin ligase 
component necessary for the degradation of Sic1p. Subsequently, it was isolated in a 
two-hybrid assay to find interacting partners of Cyclin F; Cyclin F had previously been 
identified as a suppressor of cdc4-1 mutant (Bai et al., 1994). The analysis of the cyclin 
F sequence revealed a novel motif termed the F-box domain to which Skp1p binds.  
 It was in 1997 that two groups showed that Skp1p was part of a complex which 
they term the Skp1p-Cullin/Cdc5-F-box (SCFCdc4) in which Cdc4p is the F-box protein 
(Skowyra et al., 1997 and Feldman et al., 1997). This E3 ubiquitin ligase was revealed 
to work with E1 and Cdc34p, an ubiquitin conjugating enzyme E2, to ubiquitylate S-
phase Cdk inhibitor Sic1p (Feldman et al., 1997). Skowyra et al. (1997) also observed 
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that another F-box protein Grr1p was capable of reconstituting the SCF ligase with 
Skp1p and Cullin1p/Cdc53p. This E3 ligase targeted phosphorylated Cln1p rather than 
Sic1p. 
 The F-box protein (FBP) acts like a bridge linking the substrates to be degraded 
to the SCF ligase. Today, some 67 human F-box proteins have been identified (Jin et 
al., 2004) and these proteins are categorized into three groups according to their 
substrate-binding domains they possess in addition to the F-box domain. These 
substrate-binding domains are found to be located at the carboxyl-terminal of the F-box 
proteins (Cenciarelli et al., 1999; Winston et al., 1999). One group of FBPs is termed 
FBWs whereby ‘FB’ is for F-box and ‘W’ for the WD-40 repeat domain. Those FBPs 
with leucine-rich repeats (LRRs) (Kobe and Kajava, 2001) are called FBLs, and the last 
group consist of proteins which do not fall into the above two categories, but contain a 
variety of protein motifs known as FBXs. In this third class of FBPs, protein-protein 
interaction domains like the proline-rich sequences, zinc-finger domain, and the helix-
turn-helix sequences are present. However, the substrates for many of the F-box 
proteins are still not known. 
 One of the most well-known functions of the SCF complexes is the role they 
play in regulation of cell-cycle progression, specifically via the cyclins and their cyclin-
dependent kinases (Cdks). The various F-box proteins Skp2p, β-Trcp1p, Cdc4p bring 
their substrates to the SCF ligase, resulting in their ubiquitylation and subsequently 
degradation. For instance, SCFSkp2 ubiquitylates phosphorylated p27, leading to the 
activation of Cdk1p and Cdk2p at the G1-S phase transition (Sheaff et al., 1997; 
Montagnoli et al., 1999; Vlach et al., 1997). As for SCFCdc4, it targets cyclin E for 
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ubiquitylation; for cyclin E to be degraded, it must first be phosphorylated by Cdk2p 
and glycogen-synthase kinase 3β (Koepp et al., 2001; Strohmaier et al., 2001).  
 
2.2.3.2 Structure of Skp1p 
 Studies have been conducted to understand the interaction of Skp1 and the F-
box protein. Schulman et al. (2000) published the crystal structure of Skp2p binding to 
Skp1p, and the structure is said to resemble a sickle where Skp1p and the F-box portion 
of Skp2p is the handle and the seven leucine rich repeats (LRR) of Skp2p looking like 
the blade (Figure 5). In Figure 5, the core interface referred to the region where the 
sequences of Skp1p and the F-box proteins are highly conserved in their respective 
families, whereas the variable interface is termed as such because the structural 
elements here are not conserved in their families. As mentioned earlier, Skp1p also 
interacts with Cul1p, through the N-terminal BTB/POZ domain fold. Biochemical 
studies by Ng et al. (1998) showed that dimeric form of Skp1p was observed, but the 
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Figure 5: Structure of the Skp1p-Skp2p complex.  
Reprinted by permission from Macmillan Publishers Ltd: Nature, Insights into SCF 
ubiquitin ligases from the structure of the Skp1-Skp2 complex, Schulman et al. 408(6810), 
381-6; copyright (2000). 
Skp1p is shown in blue and Skp2p is shown in red. The boundaries of the BTB/POZ fold, the C-
terminal helical extension of Skp1p and of the F-box, the three non-canonical LRRs, the seven 
canonical LRRs and the C-terminal tail of Skp2p are shown in the diagram below the structure. 
The 100-residue N-terminal Skp2p region missing from the crystallized protein is indicated 
(dashed line). The second LRR has a partially disordered loop instead of the helix characteristic 




2.2.3.3 Skp1p: other functions other than in the SCF complex 
 From the various experiments done in yeast, it was clear that Skp1p had other 
functions either than its role in the SCF ligase. In 1996, Connelly and Hieter were 
searching for suppressors of kinetochore mutation ctf13-30 in S. cerevisiae, and 
discovered a fourth subunit of the CBF3 kinetochore complex. These complexes are 
important for the attachment of chromosomes to the mitotic spindle, and are essential 
for high-fidelity segregation of chromosomes during cell division. They named the 
subunit suppressor of kinetochore protein 1, incidentally also abbreviated as SKP1. The 
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latter had high homology to the human homolog S-phase associated kinase (Skp1) 
found by Zhang et al. (1995) which was thought to play a role in cell cycle regulation 
(mentioned above). Thus Connelly and Hieter (1996) suggested that Skp1p is the link 
between kinetochore complex and cell cycle progression. It was later shown that 
ySkp1p interacts with Ctf13p, resulting in the phosphorylation of Ctf13p, which then 
activates the centromere-protein/transcription factor CBF3 kinetochore complex 
(Kaplan et al., 1997). In a bid to better understand the yeast kinetochore complex, a 
screen was carried out to identify suppressors of skp1-4 mutant (Kitagawa et al., 1999). 
A novel Skp1 interacting gene was isolated from S. cerevisiae, and termed Suppressor 
of G2 allele of skp1 (SGT1). Subsequently, the interaction of ySgt1p and ySkp1p was 
found to be essential for the formation of the CBF3 kinetochore complex (Rodrigo-
Brenni et al., 2004), and the interaction was regulated by Hsp90 chaperones 
(Lingelbach and Kaplan, 2004).  
 Skp1p has also been found to interact with another protein, F-box protein Rcy1p 
in S. cerevisiae, and the complex formed is important in endocytosis and recycling of 
plasma membrane sensitive attachment receptor protein (v-SNARE) (Galan et al., 
2001). Although Rcy1p binds to Skp1p through its F-box domain, the interaction of 
Skp1p and Rcy1p does not form an SCF complex.  
 In a screen for novel interacting partners of ySkp1p and yCdc53p using mass 
spectrometry, two proteins were isolated and termed Rav1p and Rav2p (Seol et al., 
2001). It was found that these two proteins together with ySkp1p form a complex which 
the authors have called the ‘regulator of the H+ ATPase of the vacuolar and endosomal 
membranes’ (RAVE). Both the Rav1p and Rav2p proteins did not have any F-box 
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sequence motif observed in the F-box proteins, indicating that Skp1p is able to bind to 
proteins without F-box motif. As the RAVE complex has no link to ubiquitin ligase 
activity, it is suggested that Skp1p is likely to have roles that are not related to 
ubiquitination. 
 The fact that proteins like Sgt1p, Rav1p and Rav2p do not have an F-box motif 
present in many of the proteins that interact with Skp1p indicates that Skp1p may have 
a wider role in different cellular processes either than its role in SCF E3 ligase 
ubiquitylation.  
  
2.2.3.4 Evolutionary implications of Skp1 
 Studies have identified only one functional Skp1 protein in human and yeasts, 
but there are numerous Skp1 proteins identified in Arabidopsis thalina, Caenorhabditis 
elegans, and Drosophila melanogastser (Farras et al., 2001; Nayak et al., 2002; 
Yamanaka et al., 2002). Kong et al. (2004) has shown that in some plant and animal 
species which have multiple SKP1 homologs, the SKP1 gene has evolved at highly 
heterogeneous rates. Comparisons of the various protein sequences of Skp1p taken from 
Blast searches have been carried out, and it was found that no homolog of Skp1p exist 
in Eubacteria or Archaea.  
 
2.2.4 Ubiquitin-proteasome system and transcription 
 The transcriptional regulation of genes and the ubiquitin-proteasome pathways 
are two major cellular processes which have been studied independently in the past. 
However, to get the whole picture of how genes are regulated, these two fields have 
now been linked together. Conventionally, the ubiquitylation of proteins has always 
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been a marker for its degradation by the proteasome complex, but recent investigations 
revealed there is more than meets the eye. The recent work on how ubiquitin-
proteasome pathway and transcription are intertwined will be discussed below. 
 One clear example of how modification by ubiquitin affects cellular processes is 
the mono-ubiquitylation of histones like histones H2A in higher eukaryotes (Goldknopf 
et al., 1975), H2B in eukaryotes (West and Bonner, 1980), H3 in elongation spermatids 
of rat testes (Chen et al., 1998) and Drosophila H1 (Pham and Sauer, 2000). The 
modification of H2B with a single ubiquitin molecule has been recognized since fifteen 
years ago, but it was only recently that the function of this modification is understood 
(Zhang, 2003). Robzyk et al. (2000) first discovered that Rad6 is the enzyme 
responsible for the conjugation of a single ubiquitin moiety to histone H2B in S. 
cerevisiae at lysine 123. Subsequently, it was discovered that there was cross-talk 
between mono-ubiquitylation of H2B and the methylation status of lysine 4 and lysine 
79 of histone H3 (Sun and Allis, 2002; Ng et al., 2002).   
 Interestingly, some complexes that are not related to the ubiquitin-proteasome 
system are now discovered to possess enzymatic activity that suggests otherwise. For 
instance, the Drosophila coactivator TATA-binding protein (TBP)-associated factor 
TAFII250 was shown to be capable of mono-ubiquitylating linker histone H1 in vitro 
(Pham and Sauer, 2000). Mutations which affect the ability of TAFII 250 to function as 
an ubiquitin-conjugating enzyme reduced the modified state of H1 and affected the 
transcription of genes by the maternal activator Dorsal. And there is the 
deubiquitylation of histone H2B by Ub-specific proteases (Ubps). For this, Henry et al. 
(2003) observed that Ubp8p, a component of the Spt-Ada-Gcn5-acetyltransferase 
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(SAGA) remodeling complex, is required for deubiquitylation of histone H2B. It is also 
intriguing to discover that the components of the proteasome complex, conventionally 
thought to function in the proteolysis of poly-ubiquitylated proteins, are involved in 
transcription. Specifically, mutations of the 19S regulatory particle Sug1 and Sug2 
result in defects in transcription elongation as seen by the sensitivity of yeast cells to 6-
azauracil (Ferdous et al., 2001). In fact, Sug1 had been isolated to interact with several 
transcription factors like Gal4, TBP and TFIIH (Swaffield et al., 1995; Melcher and 
Johnston, 1995; Weeda et al., 1997). One recent finding is that the 19S regulatory 
particle is able to regulate the SAGA co-activator via its ATPase activity, resulting in 
the stimulation of interactions between SAGA and transcription activators (Lee et al., 
2005). These findings suggest that a complex has a high probability of playing multiply 
roles due to the enzymatic activities of the various subunits it possesses. 
 There is one more piece of compelling evidence to strengthen the connection 
between ubiquitin-proteasome system and transcription, and that is the fact that there is 
an overlap between the transcriptional activation domains (TADs) and degradation 
signals known as degrons (Salghetti et al., 2000). It was shown that for unstable 
transcription factors like Myc and Gcn4p, the activation domain and destructive element 
possess overlapping sequences; this suggests that these transcription factors are 
degraded after the activation of transcription (Salghetti et al., 2001). Interestingly, the 
model suggested by Muratani et al. (2005) provides evidence that the activation of Gal4 
target genes requires the poly-ubiquitylation of the transcriptional activator Gal4 and its 
proteolysis. In particular, the turnover of Gal4p affects the GAL1 mRNA at the 
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postinitiation step, therefore suggesting that this modification is required for the proper 
processing of transcripts. 
 Other than the ubiquitylation of transcription factors, the ubiquitylation of RNA 
polymerase II has also been reported; in cells with induced DNA-damaged, there is an 
increase in the ubiquitylated form of the RNA polymerase II (Ratner et al., 1998). This 
is known as the transcription coupled repair (TCR) where damage to actively 
transcribed DNA can be repaired in a process that involves the ubiquitylation and 
presumably the degradation of RNA polymerase II. Lee et al. (2002) showed a 
correlation between arrest of RNA polymerase II in transcription and ubiquitylation in 
vitro. In addition, Somesh et al. (2005) observed that transcriptional arrest which is not 
caused by DNA-damage can also result in the ubiquitylation of RNA polymerase II. 
Therefore, these results suggest a model that when the RNAPII undergoes 
transcriptional arrest, it becomes ubiquitylated and is presumed to be destroyed by the 
proteasome. In the event of DNA lesions, the degradation of polymerase II allows the 
repair machinery access to the damaged DNA. Therefore the expression of these genes 
is halted until the repair of the damaged DNA is completed. Similarly, RNA polymerase 
would be degraded if it is stalled during the elongation process as irreversibly stalled 
polymerase may compromise cell viability (Svejstrup, 2003). A proposed model of how 
the ubiquitin-proteasome pathway and transcription regulation are linked is shown in 
Figure 6 (Muratani and Tansey, 2003). In the model, an activator binds at the promoter 
region, and results in the recruitment of the ubiquitin ligase complexes. The latter would 
cause the ubiquitylation of proteins like the activator, histones and RNAPII. As a 
consequence, the proteasome complex is then recruited to the site, and destroys the 
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activator. In addition, the proteasome complex is also thought to convert the initiation 




Figure 6: A unified model?    
Reproduced with permission from Nature Reviews Molecular Cell Biology Muratani and 
Tansey, How the ubiquitin-proteasome system controls transcription, Nature Rev. Mol. 
Cell Biol 4(3); 192-201; copyright (2003) Macmillan Magazines Ltd. 
In this model, the ubiquitin (Ub)–proteasome system regulates transcription at numerous levels. 
(a) Interactions of an activator with the general transcriptional machinery (green) functions to 
(b) recruit ubiquitin ligase(s) to the site of transcription and ubiquitylates many factors, 
including the activator, RNA polymerase II (pol II) and histones. (c) These ubiquitylation 
events in turn recruit the 26S proteasome, which (d) simultaneously destroys the activator and 
promotes elongation of transcription by pol II. Importantly, this proposed mechanism limits 
uncontrolled transcription in two ways — by destroying the activator at each cycle of promoter 
'firing' and by ensuring that interactions between pol II and the proteasome are made in an 




2.3 Protein-protein interaction systems 
The yeast two-hybrid system developed by Fields and Song (1989) is probably 
the most widely used assay to study protein-protein interactions. This genetic assay is 
carried out in Saccharomyces cerevisiae, and its principle is based on the fact that a 
transcription factor can be divided into two domains that are functionally distinct: the 
DNA binding domain (DBD) and the transcription activation domain (AD) (Brent and 
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Ptashne, 1985; Keegan et al., 1986). If these two domains are physically separated and 
do not interact, transcription will not occur on responsive genes. Activation of 
transcription would only occur when the DBD domain and AD domains are brought 
together. Thus based on the these observations, Fields and Song (1989) realized that 
they could have a pair of interacting proteins each fused to either domain of the yeast 
Gal4 transcription factor, and so the assay was established. The original yeast two-
hybrid system is based on transcriptional readout of a single reporter gene, but in the 
last sixteen years many other variants of the original system has surfaced. Yeast strains 
carry more than one reporter gene to decrease the chances of having false-positives and 
there are also systems using the DNA binding domain of bacterial repressor protein 
LexA with the activation domain from Escherichia coli (Causier, 2004).  However, 
there are several disadvantages in using such systems. Firstly, protein interactions in the 
yeast two-hybrid systems must occur in the nucleus, thus the analysis of hydrophobic 
proteins like trans-membrane proteins would be futile. As such, false negative results 
may arise. Secondly, the assay excludes transcription activators as these proteins may 
interact with the transcription machinery and cause the false positives in the absence of 
true protein-protein interaction; transcriptional repressors are not suitable, too. 
 Other methods to test for interacting proteins in vivo other than yeast two-
hybrid systems have been published. Two examples are the son of sevenless (SOS) 
recruitment system (SRS) (Aronheim et al., 1994) and Ras recruitment system (RRS) 
(Broder et al., 1998). Unlike the yeast two-hybrid assays that depend on transcription 
readouts, these protein recruitment methods are monitored by cell viability in a 
temperature sensitive yeast strain. Therefore, these systems can be employed to study 
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transcriptional factors. The main disadvantage of these assays is that the use is restricted 
to either nuclear or cytoplasmic proteins, and membrane proteins cannot be analyzed 
(Aronheim, 2000). On the other hand, these methods enable us to map domains of 
proteins which are responsible for the translocation of the proteins to the plasma 
membrane. Recently, the development of the reverse RRS (Hubsman et al., 2001) now 
allows the use of membrane proteins as bait. This assay can be used for characterization 
of known interactions as well as isolation of new interacting partners in a library screen 
approach. The RNA polymerase III based two-hybrid system is another assay that can 
be used in the study of transcription factors (Marsolier et al., 1997). This system is 
based on the fact that different transcription factors are involved in the regulation of 
RNA polymerase II and RNA polymerase III. 
 
2.3.1 Mammalian protein-protein interaction systems 
 Although there are several systems available to screen mammalian proteins in S. 
cerevisiae, it would still be best to validate the protein-protein interactions in 
mammalian cells. This is because the modification system in yeast differs from 
mammalian cells, and in higher eukaryotes, the conditions necessary for folding, 
processing and activation of mammalian proteins are already present. Several methods 
to detect protein-protein interactions in mammalian cells have been established and are 
discussed below. 
 The mammalian protein-protein interaction trap (MAPPIT) based on cytokine 
receptor developed by Eyckerman et al. (2001) is an increasingly popular screening 
method in mammalian cells. This cytokine receptor-based two-hybrid method is based 
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on JAK and signal transducers and activators of transcription (STAT) signaling 
pathway. The key advantage of this system is the detection of modification dependent 
protein-protein interactions; this is because the read-out is ligand-dependent. Another 
novel strategy of examining protein-protein interaction in mammalian cells is based on 
receptor engagement, and therefore termed selection of protein interactions by receptor 
engagement (SPIRE) (Ellmark et al., 2004). Here, the proteins are expressed on the 
surface of mammalian cells, which therefore allows the detection of proteins that are 
expressed on the extracellular side. One of the latest assays to probe for interacting 
partners in mammalian cells is the dual-light reporter system (Nasim and Trembath, 
2005). One key feature of this system is that it does not depend on a single reporter 
function; this is advantageous as it does not rely on transfection efficiencies. Instead the 
method is comprised of two independent gene expression units under the same promoter 
on a single plasmid. The upstream reporter is transcribed once the plasmid is introduced 
into mammalian cells, whereas the downstream reporter would only be expressed as a 
result of an interaction. Subsequently, a ratio of the two reporter gene can be obtained 
for semi-quantitation purposes. 
 
2.3.2 Other new technologies to study protein-protein interactions 
 Currently, the key technologies used to identify proteins and their interacting 
partners, and to characterize the interactions include the 2-D electrophoresis, mass 
spectrometry and multidimensional protein identification technology (MudPIT) 
(Washburn et al., 2001). There are also the high throughput technologies available to 
study protein-protein interactions on a large scale. For instance, protein array chips are 
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gaining popularity as an in vitro screening method. Other in vivo methods include 
fluorescence resonance-energy transfer (FRET) and high through-put yeast two-hybrid 
based on mating of yeast (Wallrabe and Periasamy, 2005).  
 
2.3.3 The split-ubiquitin system 
The split-ubiquitin system is the most commonly used alternative to the standard 
yeast two-hybrid assay (Auerbach et al., 2002), and it was originally developed by 
Johnsson and Varshavsky (1994). 
 
2.3.3.1 Principles of the split-ubiquitin system 
The original assay is based on conditional proteolysis that occurs upon the 
reassociation of the N- and C- terminal halves of ubiquitin designated Nub and Cub 
respectively. Each half of ubiquitin is fused to either protein of interest. Should the two 
proteins interact, the two halves of ubiquitin would be brought together in close 
proximity. This reconstituted native-like ubiquitin is recognized by ubiquitin specific 
proteases (UBPs), and a reporter attached to Cub is then released. As a result, the 
reduction in size of the reporter protein can easily be detected through Western blot 
(Dünnwald et al., 1999). Because UBPs are present in the cytosol as well as in the 
nucleus (Varshavsky, 1997; Byrd et al., 1998), this assay can be used to probe protein-
protein interactions that do not occur in the nucleus. This overcomes a limitation of the 
standard yeast two-hybrid assays in that protein-protein interactions are required to 
occur in the nucleus. Thus the split-ubiquitin assay has been used to investigate 
membrane proteins in their native environment (Dünnwald et al., 1999). Another 
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difference between conventional yeast two-hybrid system and the split-ubiquitin assay 
is that the latter does not depend on transcriptional readout. This enables the application 
of split-ubiquitin system in the analysis of strong transcription factors as seen in the 
work by Wellhausen and Lehming (1999). 
To decrease the chances of having spontaneous interactions between Nub and Cub 
without any actual interaction of the two proteins, some Nub mutants were constructed 
(Johnsson and Varshavsky, 1994). This results in a more sensitive assay, as it allows us 
to adjust for the background level. Wild type Nub carries an isoleucine in position 13, 
and the two mutations were created such that Nub now carries an alanine (NubA) or 
glycine (NubG) at that position. The strength of interaction with Cub as compared to wild 
type Nub is reduced in NubA, and for NubG, it is further decreased. This allows us to have 
some quantitative analysis of the strength of protein-protein interactions. 
This assay enables the detection of interactions between two proteins, but has a 
disadvantage in that it is not possible for the selection of new interacting partners from 
random fusion library. Two variants of the original assay have been reported to date: 
one is based on conditional compartmentalization (Stagljar et al., 1998), while the basis 
of the other strategy is conditional protein degradation (Wittke et al., 1999). 
 
2.3.3.2 The conditional compartmentalization design 
 The basis of this design is that a transcriptional activator can only exert its 
function if it is present in the nucleus. In the report by Stagljar et al. (1998), Wbp1p, a 
transmembrane protein anchored at the endoplasmic reticulum (ER) was fused to Cub 
and the artificial activator LexA-VP-16. The latter is able to bind to LexA binding sites 
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(Vojtek et al., 1993) upstream of  reporter genes like HIS3 and lacZ, thereby activating 
their  transcription. This tripartite fusion of Wbp1-Cub-LexA-VP16 was retained at the 
membrane and is unable to enter the nucleus. Thus the yeast was not able to grow on 
plates that lack histidine, and when plated on X-gal plates, white colonies were 
observed. Ost1p was the other protein fused to Nub. Both Wbp1p and Ost1p are essential 
components of the yeast oligosaccharyltransferase complex, and the co-expression of 
these two proteins with their fusion partners resulted in their interaction. Consequently, 
the two halves of ubiquitin reassembled into a native-like ubiquitin, and the Ubps 
cleaved off the LexA-VP1 fusion. This activator then entered the nucleus and activated 
the transcription of the two reporter genes; the yeast was now able to grow on plates 
lacking histidine, and blue colonies were observed upon plating onto X-gal plates.  
 The advantage of this assay is that the same yeast strain used in conventional 
yeast two-hybrid assays is applicable here (Vojtek et al., 1993). However, this study is 
limited as only proteins that do not localize to the nucleus can be tested.  
 
2.3.3.3 The conditional degradation design 
This strategy was first described in S. cerevisiae by Wittke et al. (1999), and 
subsequently adapted for mammalian cells (Rojo-Niersbach et al., 2000).  
The main principle of this system is the N-end rule, which states that the N-
terminal amino acid mediates the in vivo half-life of a protein (Varshavsky, 1996). This 
pathway is present in organisms like Escherichia coli, S. cerevisiae, and mammalian 
cells. In eukaryotes, the N-end rule is part of the ubiquitin system, and in addition to a 
destabilizing N-terminal residue, an internal lysine is required (Varshavsky, 1997). The 
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destabilizing amino acid residues in S. cerevisiae fall into two groups: basic residues 
like arginine, lysine and histidine, or bulky hydrophobic residues, like leucine, 
phenylalanine, tyrosine, tryptophan and isoleucine. There are also stabilizing N-terminal 
residues like methionine, alanine, glycine, serine, threonine, cysteine, valine and proline 
(Varshavsky et al., 2000). Ubr1p, a RING finger-containing E3 ubiquitin ligase, 
recognizes the N-terminal residues; this enzyme is responsible for the addition of a 
multi-ubiquitin chain to the internal lysine residue of the substrate (Dohmen et al., 
1991). As a result, the ubiquitylated substrate is degraded by 26S proteasome, an ATP-
dependent multisubunit protease. Arginine is the most destabilizing residue as shown by 
Varshavsky (1995), and thus this property is exploited in subsequent split-ubiquitin 
systems where the first residues of reporter proteins have been substituted with an 
arginine.  
For the selection system in yeast (Wittke et al., 1999), the first amino acid in 
reporter protein orotidine-5’-phosphate decarboxylase (Ura3) had been replaced by 
arginine (RUra3). One protein was fused to Nub, while a second protein was fused to 
Cub-RUra3. Should the two proteins interact inside the cell, a native-like ubiquitin 
would be formed, and the Ubps cleave off the RUra3 moiety. As a result, the reporter 
protein was rapidly degraded and the phenotype of the yeast becomes uracil-deficient. 
Protein-protein interactions can be selected for with the help of 5-fluoroorotic acid (5-
FOA), a drug counterselecting Ura3 enzymatic activity. Figure 7 shows the events that 
occur in a split-ubiquitin screen using Gal4 as bait (Laser et al., 2000). 
 
 






This set-up has been used to screen a genomic library consisting of S. cerevisiae 
fragments fused to Nub as the prey and the transcriptional repressor Tup1p and the 
transcriptional activator Gal4p as baits (Laser et al., 2000; Pätzold and Lehming, 2001; 
Kerkmann and Lehming, 2001). In the screen performed with Gal4p as bait, four new 
binding partners were discovered (Laser et al., 2000), and in the screen with Tup1p as 
bait yielded 12 novel binding partners for this transcriptional repressor (Kerkmann and 
Lehming, 2001). However, some artifacts emerged in the screening process, and some 
of these proteins interacted with the Cub part of the bait. The artifacts include Gog5p and 
Ymd8p which are small molecule transporters that cause FOA resistance when 
Figure 7: The split-ubiquitin system in yeast 
based on the conditional degradation design.  
 
Reproduced from PNAS, A new screen for 
protein interactions reveals that the 
Saccharomyces cerevisiae high mobility group 
proteins Nhp6A/B are involved in the 
regulation of the GAL1 promoter, Laser et al.,
2000, 97(25), 13732-13737; Copyright (2000) 
National Academy of Sciences, U.S.A. 
 
Ubiquitin, fused to the N terminus of the Ura3 
displaying an arginine as its first amino acid 
(RUra3), is recognized by the UBPs (line 1). A 
fusion protein containing Gal4, Cub and the 
reporter RUra3 is not cleaved by the Ubps (line 
2). The fusion is enzymatically active and the 
yeast cells are phenotypically uracil prototrophic 
and sensitive to 5-FOA. The co-expression of Nub
fused to a protein X together with Gal4-Cub-
RUra3 leads to an increase in the local 
concentrations of Nub and Cub if Gal4 and X 
interact inside the cell. A native-like ubiquitin is 
formed, and the Gal4-Cub-RUra3 fusion is 
cleaved. The enzymes of the N-end rule degrade 
the free RUra3 reporter rapidly. Therefore the 
protein interaction between Gal4 and X can be 
detected by the absence of growth on plates 
lacking uracil and by the growth on plates 
containing 5-FOA. 
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overexpressed, ubiquitin hydrolase Mum2p and ubiquitin conjugating enzyme Ubc1p. 
Furthermore the protein-protein interactions detected by the split-ubiquitin assay may 
not be due to direct interactions, but due to close proximity of the two proteins. Thus the 
isolated proteins have to be tested in vitro to determine if their interactions are direct 
ones. All proteins pair tested were found to be direct interactions except for Tup1p and 
Cdc73p. Further work carried out by Kerkmann and Lehming (2001) revealed that 
Cdc73p and Tup1p regulate a common set of genes. Thus the screen had identified the 
close proximity of the two proteins as they co-occupy the promoter even though these 
two protein were not directly interacting. It was also shown that the screening of the 
genomic library could not detect all possible protein interactions. Gromöller and 
Lehming (2000) showed that indeed Tup1p interacts with Srb7p, a essential subunit of 
the holoenzyme for transcription. Because the screening of the library had been carried 
out such that the N-terminus of Srb7p was fused to Nub and therefore creating Nub-Srb7 
fusion, the interaction between Srb7p and Tup1p was not detected previously as the free 
N-terminus of Srb7p was required for the interaction. 
A third class of reporter gene has been developed using the green fluorescent 
protein (GFP) fused to Cub (Cub-RGFP) (Laser et al., 2000).  Theoretically, this system 
does not limit the study of protein-protein interactions to either yeast or mammalian 
cells, and is generally applicable to all eukaryotic cells. Gromöller and Lehming (2000) 
have applied this variant of the split-ubiquitin system to test the interactions between 
Tup1p and its known potential targets. S. cerevisiae cells expressing Srb7-Cub-RGFP 
show strong nuclear green fluorescence. When Nub-Tup1p was co-expressed with Srb7-
Cub-RGFP, the nuclear localized GFP signal was destroyed. This indicated that the 
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interaction between Tup1p and Srb7 caused the local concentrations of Cub and Nub to 
increase, and subsequently native-like ubiquitin were formed. Cleavage by Ubps leads 
to the degradation of the GFP reporter by the N-end rule enzymes. 
 
2.3.3.4 Modified split-ubiquitin systems in mammalian cells 
As for the application of the split-ubiquitin system in mammalian cells, a 
different reporter gene was used. Rojo-Niersbach et al. (2000) have shown the use of an 
RGpt2 reporter protein in selection of protein interactions in the human fibroblast cell 
line HT1080HPRT- (Pellegrini et al., 1989). This cell line lacks the enzyme 
hypoxanthine-guanine phosphoribosyltransferase (HPRT), and is therefore sensitive to 
medium containing hypoxanthine/aminopterin/thymine (HAT), but is resistant in 
medium containing 6-thioguanine (6TG). The guanine phosphoryltransferase 2 (gpt2) 
gene of E. coli is able to complement the deficiency. This system was used to 
investigate the interaction between human TATA-binding protein 1 (hTBP1) and the C-
terminal domain of human nuclear factor κB (NF-κB) termed p65C, and interaction 
between Homo sapiens nuclear autoantigen (hSP100B) and human heterochromatin 
protein 1α (hHP1α) in living cells. These two interactions had been previously 
characterized in vitro (Kerr et al., 1993; Lehming et al., 1998; Seeler, et al., 1998). 
Figure 8 shows a schematic representation of system set-up. The HT1080HPRT- cell 
line expressing the tripartite fusion of p65C-Cub-Rgpt2 alone should display HAT 
resistance and 6TG sensitivity (Figure 8a). Nub-hTBP1p was then co-expressed in the 
cells. Should p65C and hTBP1p interact in vivo, the two proteins would be brought in 
close proximities (Figure 8b). This resulted in the reconstitution of the ubiquitin, and 
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Ubps would cleave the p65C-Cub-RGpt2 fusion (Figure 8c). Thus, the RGpt2 reporter 
protein was rapidly degraded by enzymes of the N-end rule (Figure 8d). This lead to a 
change in phenotype of the cell line to HAT-sensitive and 6TG resistant.  
 
   
 
Figure 8: Schematic illustration of the mammalian split-ubiquitin system. 
Reproduced with permission  from Rojo-Niersbach et al. (2000), A new method for the 
selection of protein interactions in mammalian cells, 348, 585-590, © the Biochemical 
Society. 
(a) An HT1080HPRT- cell line expressing p65C-Cub-Rgpt2 is HAT-resistant (HATR) and 
6TG sensitive (6TGS). (b and c) Should Nub-hTBP1 be co-expressed, hTBP1 and p65C bind 
to each other inside living cell. As a consequence, native-like ubiquitin is reconstituted and 
the p65C-Cub-Rgpt2 fusion protein is cleaved behind Cub. (d) The cleavage product Rgpt2 is 




2.3.3.5 Recent applications of the split-ubiquitin systems 
The modified split-ubiquitin system based in yeast has been widely used to 
study membrane proteins involved in signaling and transporters in yeast, plants and 
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mammals, and to investigate interacting partners of membrane proteins with enzymatic 
functions like oligosaccharyl transferase in yeast (Pasch et al., 2005; Yan et al., 2005; 
Pandey and Assmann, 2004; Schulze et al., 2003). This modified split-ubiquitin system 
has also been used for studying of viral membrane proteins like the Hepatitis B surface 
antigen (HBsAg) in understanding viral morphogenesis (Toh et al., 2005). In addition, 
the split-ubiquitin system has also been used to verify interactions between two 
membrane proteins. Wang et al. (2004) was reportedly the first group to use the yeast 
split-ubiquitin system based on the compartmentalization approach to screen a cDNA 
library. They used the endoplasmic reticulum membrane protein BAP31p as bait to 
screen a cDNA library for interaction proteins, and a novel human member of the 
protein tyrosine phosphatase-like B (PTPLB) family was isolated. 
 In addition, the large-scaled analysis of the integral membrane proteins of 
Saccharomyces cerevisiae was recently carried out by Miller et al. (2005) using the 
modified split-ubiquitin system. A total of 705 membrane proteins were short-listed for 
protein-protein interaction analysis, but only 365 proteins were found to be competent 
for use in the screening. Of a total of 270 screens conducted, 1, 985 interactions were 
observed. The group then went on further to use a learning algorithm, support vector 
machine (SVM) to classify the interactions to different levels. This study was successful 
in isolating novel previously undiscovered interacting candidates. As such, the coupling 
of computational tools together with experimental data in large-scale protein-protein 
interaction studies is useful in weeding out the false-positive and false-negative 
interactors. However, like for most protein-protein interaction screens, one must 
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3. MATERIALS AND METHODS 
3.1 Molecular Cloning  
3.1.1 Construction of primers 
The genomic sequence of each gene was obtained from GenBank (National 
Institute of Health); for hSKP1A, the Accession number was NM_179679. PCR primers 
were constructed such that they were at least 20 base pairs long, and had an annealing 
temperature of greater than 50ºC. Different 3’ antisense primers for the construction of 
Nub and Cub fusions were made. For the Cub 3’ antisense construct, the stop codon was 
removed, while for the Nub construct, the stop codon remained unchanged. The 5’ sense 
primer was used with either one of the 3’ antisense primers for any one PCR reaction. 
Sequences of restriction enzymes were included in the primers; this allows for the ease 
of inserting this PCR fragment into the vector. The sequences of the PCR primers are 
listed in Table 1.  
Table 1: List of primers for PCR of full-length hSKP1, hSRB7 and hSGT1. 
 
3.1.2 Polymerase Chain reaction (PCR)  
Amplification of the DNA was carried out using Expand High Fidelity PCR 
system (Boehringer Mannheim). The components of each tube were prepared as 
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indicated in Table 2. A cDNA library derived from human B cell was used as a PCR 
template for the synthesis of all open reading frames (ORFs). The samples were then 
amplified for 35 cycles. First, the cycler was preheated at 94ºC for 2 minutes before 
amplification began. Then the program for each cycle started at 94ºC for 1 minute, 
followed by 50ºC for 1 minute, and 72ºC for 2 minutes. The samples were then cooled  
at 4ºC before electrophoresis on an agarose gel. 
Table 2: Components of each PCR reaction sample. 
 
3.1.3 Agarose gel electrophoresis 
A 1% agarose gel was cast using 100ml of 1 x Tris Borate EDTA (TBE) buffer 
and 1g of agarose (GibcoBRL, Life Technologies). 3µl of ethidium bromide (Bio-Rad 
Laboratories) was added to the gel to allow the direct visualization of the DNA in the 
gel. 10µl of PCR samples were loaded with 2µl of 6 times loading dye, and pGEM 
DNA marker (Promega Corporation, USA) was used. The gel was electrophorized at a 




Reagent Volume (µl)/ 1 sample Final Concentration 
10 X PCR buffer with MgCl2 5 1X 
dNTP 1 0.2mM 
Primer 1 – 5’ sense 0.5 50µM 
Primer 2 – 3’ antisense 0.5 50µM 
Template DNA 0.1 2 µg/µl 
Sterile water 42.4 -- 
High fidelity polymerase 0.5 1 unit 
Total volume 50 -- 
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3.1.4 DNA purification  
Only PCR fragments that are of the expected size were subsequently purified. 
Restriction digestion mixes were also subjected to DNA purification after incubation to 
remove the enzymes. This process was carried out using High Pure PCR Product 
purification kit (Boehringer Mannheim), and according to manufacturer’s protocol. The 
purified DNA was resuspended in appropriate amounts of sterile water. 
 
3.1.5 Restriction digestion of plasmids and inserts 
The plasmids for mammalian work used have been described previously (Rojo-
Niersbach et al., 2000). The Cub vector had a XhoI/ApaI-cut fragment containing the C-
terminus of ubiquitin fused to guanine phosphoryltransferase 2 (Gpt2), modified to 
begin with an arginine residue, placed in pcDNA3 + zeocin plasmids (Invitrogen). As 
for the Nub fusion vector, a HindIII/EcoRI-restricted PCR fragment containing Nub had 
been inserted into pcDNA3 (Invitrogen). The PCR fragments of Srb7 was cleaved with 
MunI/XhoI, and inserted into the pcDNA3-Cub-RGpt2 vector that was cut with EcoRI 
and XhoI. The PCR fragment of Skp1 was cleaved with MunI/SalI, and ligated with 
pcDNA3-NubI that was cut with EcoRI and XhoI. The reaction was carried out overnight 
at 37ºC in a total volume of 100µl, and consisted of 20µl of the purified PCR fragments, 
and 1µl of each enzyme used for the restriction. The expression plasmids for S. 
cerevisiae have been described previously in Laser et al. (2000). The plasmids are the 
single-copy PCUP1- Cub-RUra314 fusion vector and the single-copy pACNX-NubIBC. 
Cloning of hSkp1 into the Cub-RUra3 vectors was between the restriction sites BamHI 
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and SalI site. As for the Nub fusion vectors, they were cut with EcoRI and NotI enzymes 
overnight and purified as described above.  
 
3.1.6 Ligation and transformation into Escherichia coli cells 
Ligation was carried out by mixing 1µl of the cut vector, 3µl of cut fragment and 
0.5µl of the T4 ligase (Boehringer Mannhein, Germany) in a 1.5ml microtube. The 
reaction was topped up with 1µl of 10X ligation buffer (Boehringer Mannhein, 
Germany), and 4.5µl of sterile water, bringing the total volume to 10µl. This mix was 
placed overnight at 4oC. 
Transformations of the vectors into competent DH5α E. coli cells were carried 
out to amplify the plasmid. To 50µl of vector mix, 50µl of DH5α was added and the 
mixture was incubated on ice for 20 minutes. Following this, the mixture was placed in 
the water bath at 42oC for 90 seconds. 400µl of Luria Bertani (LB) was added to the 
mixture and the tube was placed at 37oC for 1 hour. All 250µl were streaked onto LB 
agar with ampicillin (50mg/ml), and placed overnight at 37oC.  
 
3.1.7 Screening for positive transformants 
The preliminary screening for transformants was performed by plasmid 
minipreps using alkaline lysis method (Ausubel et al., 2006), and followed by 
restriction digestion analysis. 
5µl of the isolated DNA was then taken for a restriction digest to check if there 
was the correct insert. 0.25µl of each restriction enzyme was used, and the reaction was 
topped up to a final volume of 25µl with sterile distilled water and restriction buffer. 
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The restriction digestion reaction was placed at 37oC for two hours before the samples 
underwent electrophoresis on a 1% agarose gel as stated in Section 3.1.3. The plasmid 
that generated DNA fragment with the expected size after digestion was stored at -20ºC 
for retransformation in large scale preparation of plasmid DNA. 
 
3.1.8 Large scale preparation of plasmid DNA 
Retransformation of positive transformants was carried prior to the large scale 
preparation of plasmid DNA. 0.5µl of the plasmid from earlier analysis was incubated 
with 10µl of competent DH5α cells on ice for 20 minutes. This mixture was then placed 
in a 42ºC waterbath for 90 seconds. 40µl of LB solution was added to the mixture that 
was next placed at 37oC for 1 hour. 10µl of the solution was then plated onto LB agar 
with 50µg/ml ampicillin. The plasmids were then subjected to purification using the 
maxi kit (Qiagen), or by alkaline lysis and subjected to cesium chloride/ethidium 
bromide purification (Ausubel et al., 2006). 
 
3.1.9  Sequencing of samples 
Subsequently, DNA sequencing was carried out. For the DNA sequencing of 
cDNA3-Srb7-Cub-RGpt2, the forward primer that hybridizes to the T7 promoter was 5’-
taatacgactcactataggg-3’, and the reverse primer sequence that hybridized in the Cub 
region (Cub50) was 5’-cagacagcgttctacgtct-3’. As for pcDNA3-Nub1-Skp1, the forward 
primer (Nub100) was 5’-cgttaagtcgaaaattcaag-3’, and the reverse primer (TcDNA3) was 
5’-ggggaggggcaaacacaga-3’. Only one primer was used in each reaction, and cycle 
sequencing followed by the purification of the extension products was carried out as 
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followed. To 250ng of template DNA, 1.6ρmol of primer and 2µl of Terminator Ready 
Reaction Mix were added. The reaction was topped up with deionized water to 10µl. 
The following cycle parameters were used: 96ºC for 30 seconds, 50ºC for 15 seconds, 
and 60ºC for 4 minutes. Upon completion of the reaction, the contents were each 
transferred into a 1.5ml microtube that contains 80µl of ethanol/sodium acetate solution 
(consisting of 3.0µl 3M sodium acetate, pH4.6, 62.5µl of nondenatured 95% ethanol 
and 14.5µl of deionized water). The microtubes were then vortexed briefly, and left at 
room temperature for 15 minutes to precipitate the extension products. Next, the tubes 
were centrifuged at 13,000 rpm for 10 minutes, and the supernatant was carefully 
aspirated with a pipette and discarded. 500µl of 75% ethanol to rinse the pellet, and the 
microtube was centrifuged at 13,000 rpm for 5 minutes. The supernatant was then 
discarded, and the pellet was dried in a speedvac concentrator for 10 minutes. 
Subsequently, the dried samples were given to Department of Microbiology (National 
University of Singapore) for DNA sequencing. 
 
3.1.10 Cloning of small-interfering RNA (siRNA) constructs 
 The pSuper RNAi system (OligoEngine) was used to direct the intracellular 
synthesis of siRNA-like transcripts in a mammalian expression vector. The plasmid was 
a kind gift from Dr Ng Huck Hui (Genome Institute of Singapore). A unique 19-
nucleotide sequence was derived from the hSkp1 target gene (Accession number 
NM_179679) with the help of Whitehead Institute's siRNA prediction tool 
(http://jura.wi.mit.edu/bioc/siRNAext/). The lists of 19-nucleotide sequences were then 
  Material and methods 
 51
subjected to further analysis based on criterions stated in these two articles: Hsieh et al. 
(2004) and Reynolds et al. (2004). 
 The forward and reverse oligo were generated such that they had a BglII site at 
the 5’ end, while the 3’end contained the T5 sequence and any corresponding SalI site. 
The target sequence is as shown in Table 3.  
siRNA Sequence Target 
hSkp1 5’-gcactgctctgtttataat -3’ 681-703 in the 3’ untranslated region 
Table 3: The 19-nucleotide target sequence of hSkp1.  
This sequence was targeted for suppression using the pSUPER RNAi system. 
 
 The full length 60bp forward oligo sequence was 5’-
GATCCCCGCACTGCTCTGTTTATAATTTCAAGAGAATTATAAACAGAGCAGTGCTTTTTG-3’, 
and the full length 60bp reverse oligo sequence was 5’-
TCGACAAAAAGCACTGCTCTGTTTATAATTCTCTTGAAATTATAAACAGAGCAGTGCGGG-3’. 
1µg of the forward and reverse oligo (1st Base) each was annealed using annealing 
buffer (100mM potassium acetate, 30mM HEPES and 2mM magnesium acetate) and 
incubated at 95oC for 4 minutes. Subsequently, the oligos were incubated at 70oC for 10 
minutes and then at room temperature for an hour. Ligation was carried out using 
pSuper that had been digested with BglII and SalI, and transformed into E. coli DH5α 
strain and selected on LB plates containing ampicillin. Plasmids were subjected to 
alkaline lysis and gel electrophoresis to verify the presence of the insert. DNA 
sequencing was carried out using these two primers to verify that cloning was 
successful: Forward primer: 5’-tcgctatgtgttctgggaaa-3’ and reverse primer: 5’-
gctatgaccatgattacgcc-3’ hybridizing to the pSuper plasmid were used for the DNA 
sequencing. It was ensured that the entire 60bp of insert was present, and there were no 
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mutations present. As the plasmid targeted region 681-703, it was named pSuper-
hSkp1-681. Transfection into 106 HeLa cells was carried out using LipofectamineTM 
2000 (Invitrogen). Subsequently, Western Blot was carried out using an antibody 
against hSkp1 (Abcam, ab10546). 
 
3.1.11 Isolation of total RNA 
 Total RNA was isolated from 4 X 107 HeLa cells using the RNeasy Mini kit 
(Qiagen) according to the protocol for isolation of cytoplasmic RNA from animal cells 
from the manufacturer’s manual. The RNA was eluted in 60µl of water treated with 
diethyl pyrocarbonate (DEPC). Next, the absorbances of the samples were taken, and 
the concentration of the RNA was determined. The purity of the RNA was verified  by 
optical density (OD) absorption ratio OD260 nm/OD280 nm between 1.80 and 2.1. 6µl 
of the RNA was also subjected to denaturing agarose gel electrophoresis and ethidium 
bromide staining to verify the integrity and size distribution, together with 4 µl RNA 
ladder, High Range (MBI Fermentas). This was performed according to manufacturer’s 
protocol (Qiagen). The 18S and 28S bands appeared as sharp bands under UV.  
 
3.1.12 Construction of complementary DNA (cDNA) library 
 A detailed outline of the protocol is shown in Figure 9. From the cytoplasmic 
total RNA, polyA+  RNA was isolated using the Oligotex kit (Qiagen) and according to 
the mRNA spin-column protocol. 200µl of poly A+ mRNA was eluted from the spin 
column, and all the isolated mRNA was used in the construction of the cDNA library.  


























Construction of the cDNA library was carried out using the SUPERSCRIPTTM 
plasmid system with GATEWAYTM technology for cDNA synthesis and cloning 
(Invitrogen). This kit allows the directional cloning of the cDNA inserts in a specific 
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DEPC-treated water 
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Figure 9: Detailed flow diagram of procedure of cDNA synthesis and cloning. 
  Material and methods 
 54
orientation relative to the transcriptional polarity of the original mRNAs. Directional 
cloning was made possible by the primer-adapter 5’- Pgactagttctagatcgcgagcggcc 
gccc(T)15-3’ in the first strand synthesis, and the ligation of SalI adapters after the 
second strand synthesis. Size fractionation of the cDNA was not carried out; instead, 
purification was carried out using PCR column purification kit (Roche). This was 
because no radioactive dinucleotides were used in the protocol, and it would be difficult 
to analyze the yield in each fraction. 
The 5’ SalI- and 3’ NotI-digested cDNAs were then ligated into the yeast 
pACNX-NubIBC vectors in all three reading frames that have undergone restriction 
digestion with SalI and  NotI restriction enzymes. Large-scale ligation was carried out 
in a 1ml reaction mix consisting of 20µg of vectors in each reading frame, 200µl of 5X 
ligase buffer and 25µl of ligase at 4oC over the weekend. Electroporation was carried 
out using the competent E. coli DH10B cells. Following an one hour incubation at 
37oC, the cells were plated onto Luria Bertani plate containing 10µg/ml of 
chloramphenicol; a total of 59 electroporations were performed. Dilutions of 10-3 10-4 
and 10-5 were carried out to find out the total number of transformants, and 20 colonies 
were picked from this dilution plate after incubation for 24 hours at 37oC. The plasmids 
were recovered by alkaline lysis and the DNA was then subjected to restriction 
digestion by HindIII and NotI to verify the presence of inserts. As for the 59 plates, 5 ml 
of LB was used to wash the cells off the agar plates, and the culture was subjected to 
large-scale preparation of plasmids using the alkaline lysis method and subjected to 
cesium chloride /ethidium bromide purification (Ausubel et al., 2006).  
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3.1.13 Reverse-transcription polymerase chain reaction (RT-PCR) 
 Total RNA was isolated from 1 X 106 cells in each well of the 6-well plate as 
described above. 100ng of total RNA was used in the reverse transcription reaction 
(Applied Biosystems), with 1X reverse transcription buffer, 2.5µM Oligo-d(T)16 
primers, 0.5mM dNTPs, 5.5mM MgCl2, 6 units of RNase inhibitor and 18.75 units of 
reverse transcriptase in a total of 15µl per reaction. The tubes were then placed into the 
PCR machine for 10 minutes at 25oC, followed by 60 minutes at 37oC and 5 minutes at 
95oC. Real time PCR was performed using ABI Prism® 7700 (Applied Biosystems). 
Reactions were performed in 25µl volumes, containing 125nM of each primer, 1X 
SYBR® Green PCR Master Mix (Applied Biosystems), 5µl of reverse transcription 
reaction solution. Table 4 lists the primers used in the Real-time PCR. The experiments 
were performed in triplicates. The cycling parameters used for the Real time PCR were 
as follows: denaturation at 50oC for 2 minutes, 95oC for 10 minutes and subsequently 
40 amplification cycles at 95oC for 15 seconds and 60oC for 60 seconds. A dissociation 
curve was carried out after each run to ensure that no unspecific products were formed. 
 
Table 4: List of primers used for real-time PCR.  
Primers for glyceraldehyde-3-phosphate dehydrogenase (GAPD) and hHsp70B’ are as listed in 
the following journal: 1Carraro et al 2004; 2Parsian et al, 2000 
 




hGAPD Forward1 5’- ctctctgctcctcctgttcgac-3’ 
hGAPD Reverse1 5’- tgagcgatgtggctcggct-3’ 69bp 
hHsp70B’ Forward2 5’- ccccatcattgaggaggttg-3’ 
hHsp70B’ Reverse2 5’- gaagcagaagaggatgaacc-3’ 217bp 
hSkp1 Forward 5’- gcaaagagaaccagtggtgtga -3’ 
hSkp1 Reverse 5’ - aggtttgggatctgtgctcaa -3’ 205bp 
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The relative expression levels of hHsp70B’ and hSkp1 mRNA in siRNA-treated 
samples and untreated samples were determined using the comparative threshold (Ct) 
method. The fold change in expression between siRNA treated and empty vector treated 
cells were calculated using the 2-∆∆CT method (Livak and Schmittgen, 2001). 
 
3.2 Cell culture 
Two cell lines were used in this study. One cell line was the human fibroblast 
HT1080HPRT- that is lacking the gene for hypoxanthine-guanine 
phosphoribosyltransferase (HPRT). It was obtained from Sandra Pellegrini from the 
Department of Immunology, Institut Pasteur, Paris, France (Pellegrini et al., 1989). The 
other cell line was HeLa cells, a kind gift from Dr Seah Geok Teng’s lab.  
 
3.2.1 Maintenance of cell culture 
The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma 
1152, Numi preparation facility), supplemented with 10% (v/v) fetal calf serum (FCS) 
(Nalgene) in 75cm2 tissue culture flask. When the cells were 90% confluent, the cells 
were trypsinised as follows: the medium was first removed. Next, 25ml of phosphate 
buffered saline (PBS; Numi preparation facility) was added to wash the cells, and then 
discarded. 3.5ml of 1X trypsin-EDTA solution (Sigma) was added to the flask, and 
incubated for 5 minutes at room temperature before tapping the flask to dislodge the 
adhesive cells. 10ml of medium was then added to neutralize the trypsin, and 11ml of it 
was removed and placed in a 15ml tube. To the medium remaining in the flask, 20ml of 
medium was used to top up, and the flask was placed back in the 37oC carbon dioxide 
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(CO2; 5%) incubator. The 15ml tubes were centrifuged at 1,500 rpm for 5 minutes at 
15oC. The pellet was resuspended in 2ml of 10% dimethylsulfoxide (DMSO) with FCS, 
and the solution transferred into a cryopresevation vial. These vials were then stored at -
80oC or in liquid nitrogen. 
 
3.2.2 Construction of stable Cub cell lines 
Stable Cub cell lines (HT1080HPRT-::Srb7-Cub-RGpt2) were made by 
lipofectamine transfection using LIPOFECTAMINE™ 2000 reagent (Invitrogen).  
For transfection of Cub fusion plasmid, HT1080HPRT- cells were used. The day 
before the transfection, HT1080HPRT- cells were trypsinized and plated onto 6-well 
plates such that it would be 90-95% confluent on the day of transfection. For each well 
of cells to be transfected, 0.5µg of plasmid DNA pcDNA3-Srb7-Cub-RGpt2 was diluted 
in 100µl of serum-free DMEM in 1.5ml microtube. 3ml of LIPOFECTAMINE 2000 
reagent was diluted in 100µl of serum-free DMEM in 1.5ml microtube for each well of 
cells. These two solutions were combined, and mixed gently before incubation at room 
temperature for 20 minutes. This step was for the formation of DNA-lipid complexes. 
The cells were washed once with 2ml of serum-free DMEM. For each transfection, 
800µl of serum-free DMEM was added to each tube containing the lipid-DNA 
complexes and mixed gently. This diluted complex solution was then overlayed onto 
the washed cells, and the 6-well plate was incubated for 5 hours at 37oC in the 5% CO2  
incubator. 1ml of DMEM with 20% of FCS was added to the cells without removing the 
transfection mixture. The medium was replaced 24 hours following transfection.  
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48 hours after transfection, the cells were selected for gene expression of the 
zeocin marker in medium that contained 80mg/l of the zeocin. The cells in each well 
were trypsinized, and dilutions were carried out such that 10% of the cells were plated 
onto four 24-well plates. The incubation period was 14 days, and medium was replaced 
every 5 days or when necessary. 
Single colonies were picked after the two weeks, and three cell lines were 
analyzed. Each single colony was trypsinised and transferred to one well of 6-well 
plates to grow to 90% confluence before testing for phenotype. 
 
3.2.3 Construction of stable Nub cell lines 
Stable Nub cell lines were made by lipofectamine transfection similar to the 
construction of stable Cub cell lines. However, there were two key differences. Nub 
fusion plasmids were transfected into the cells that had been stably transformed with 
Cub fusion plasmids (HT1080HPRT-::Srb7-Cub-RGpt2), and the cells were selected for 
the expression of neomycin phosphotransferase encoded by the Nub fusion vector. The 
medium used for the selection of the Nub cell lines was medium containing G418 sulfate 
(400mg/l) (USB, Amersham International). The cells were diluted such that there were 
three 24-well plates with 90%, 10% and 1% of the cells on each plate.  The incubation 
time was about 14 days, and the medium was replaced every 5 days or when necessary. 
Single colonies were picked, and two stable cell lines of each construct were analyzed 
for their phenotype. 
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3.2.4 Analysis of phenotype 
For each Cub cell line construct, 10% of the cells, upon trypsinization, were 
placed in each of the three wells of a 6-well plate. To one well, 2ml of DMEM with 
10% FCS was added. The second well was supplemented with 2ml of 
hypoxanthine/aminopterin/thymidine (HAT) medium (Roche, Boehringer Mannheim). 
As for the last well, 2ml of medium with 6-thioguanine (6TG; Sigma) (15mg/l) and 
80mg/l of zeocin was added. The solutions were changed every three days. The 
procedures for analysis of phenotype in Nub constructs were similar except for the 
addition of G418 (400mg/l) to medium containing HAT in the second well. When the 
cells were 90% confluent, trypsinization was carried out, and 90% of the cells in each 
well were removed. This step was to ensure that dead cells were removed. The 
remaining cells were left to grow to 90% confluent before photographs were taken to 
analyze their phenotype.  
 
3.2.5 Transfection of plasmids and heat induction of HeLa cells for Real time 
PCR experiment 
 The experiment was carried out in 6-well plates. 1µg of plasmid was transfected 
into 90% confluent HeLa cells using 3µl of Lipofectamine 2000 (Invitrogen) according 
to manufacturer’s protocol. Heat induction was carried out at 45oC for 15 minutes, and 
subjecting the cells to recovery at 37oC for an hour (Parisan et al., 2000) before 




  Material and methods 
 60
3.3 Western blot 
3.3.1 Preparation of samples and acrylamide gels  
 Separating gels with 12% acrylamide concentrations were used in this study, 
while a 4% stacking gel was consistently used (Table 5). Formulations of SDS-
polyacrylamide separating and stacking gels are listed in Table 5. Recipes are sufficient 
for the preparation of 1 slab minigels (0.75 mm thick and 100 by 70mm2), and the 
components were mixed in the order shown. Polymerization would begin as soon as 
N,N,N’,N’-tetramethlethylene-diamine (TEMED) had been added.  
Separating gels 12% 
 3.3 ml 4.0 ml 
 4.0 ml 3.3 ml 
 2.5 ml 2.5 ml 
 100 µl 100 µl 
 100 µl 100 µl 
 4 µl 4 µl 
 10 ml 10 ml 
  
Stacking gels 4% 
 Sterile distilled water 3.0 ml 
 30% acrylamide mix 0.65 ml 
 1.0 M Tris Cl (pH6.8) 1.25 ml 
 10% SDS 50 µl 
 10% ammonium persulfate 50 µl 
 TEMED 5 µl 
 Total (for 1 gel) 5 ml 
  Table 5. Solutions for preparing gels for SDS-PAGE. 
 
3.3.2   Electrophoresis and Western blot 
50µl of PBS and 50µl of Laemmli buffer (Bio-Rad Laboratories) were added to 
resuspend the pelleted cells, and no heating of the samples at 100oC was necessary. 15µl 
of each sample was separately loaded into the sample wells, and 5µl of the molecular 
marker standard - Kaleidoscope Prestained Standards (Bio-Rad Laboratories) – was 
heated for 1 minute at 40oC before loading onto the gel. Electrophoresis was carried out 
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at 100V at room temperature. The voltage was increased to 150V when the samples had 
entered the separating gel and monitored till the dye reached the end of the gel. At the 
end of the run, the glass plates were removed from the gel stand, and the plates were 
gently pried apart.  
The next step was to transfer the separated proteins onto a nitrocellulose 
membrane using a Semi-Dry Electrophoretic Transfer Cell (Bio-Rad Laboratories). A 
sandwich was assembled by placing 4 pieces of filter papers presoaked in 1X transfer 
buffer onto the platinum anode, followed by the pre-wet nitrocellulose membrane, the 
gel and 4 more pieces of soaked filter paper. Appropriate markings were made to 
indicate the relative positions between the gel and the membrane, and air bubbles were 
carefully removed from between each layer. After the cathode and safety cover were 
placed onto the stack, the electrophoretic transfer was performed at 0.2A for 60 
minutes.  
The blotted membrane was then placed in blocking buffer that contained 5% 
non-fat dried milk in 100ml deionised water with 10 mM Tris HCl (pH7), and soaked in 
this solution for 1 hour at room temperature on an orbital shaker. This was to block non-
specific binding sites. The next step was to incubate the membrane with the primary 
antibody, the anti-haemagglutinin (HA) antibody (BabCO, Freiburg, Germany). The 
dilution was 1:10000 in 5% non-fat milk in TBST (20 mM Tris, 150 mM NaCl, 0.1% 
Tween-20). The incubation was overnight, with the tray placed on an orbital shaker. 
After three 15-minute washes with 1% non-fat milk to remove any unbound primary 
antibody, incubation with the secondary antibody - horseradish peroxidase-coupled anti-
mouse antibody (Bio-Rad, München, Germany) - was carried out next. This incubation 
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was for 2 hours at room temperature on an orbital shaker, and the dilution of the 
secondary antibody was 1:4,000 in 5% non-fat milk in TBST. Following this, three 
washes of 15 minutes each were performed using TBST. Excess wash buffer from the 
washed membrane was drained, and the nitrocellulose membrane was placed protein 
side-up on a clean surface.  
ECL Plus (Amersham Pharmacia Biotech) system was used to detect the 
proteins, and the detection reagents were prepared by mixing solution A and B in the 
ratio of 40:1. The mixed detection reagent was then pipetted onto the entire surface of 
the membrane, and allowed to incubate for 1 minute. Any excess detection reagent was 
drained off by holding the membrane gently with forceps. SaranWrap was subsequently 
used to wrap up the blot while taking care to smooth out any air bubbles, and the 
wrapped blot was placed protein side-up onto a X-ray film cassette. This next step was 
carried out in a dark room using red safe lights. A sheet of autoradiography film was 
placed on top of the membrane, and the cassette was closed to expose for 5 minutes. 
The film was developed at the darkroom at the Clinical Research Center (National 
University of Singapore). Based on the appearance of the first film, estimations were 
made to continue the second exposure of the second piece of film. 
 
3.4 Working with Saccharomyces cerevisiae 
3.4.1 Competent yeast cells and transformation 
 The yeast strain used was NLY2 (MATα, gal4-, gal80-, ade2-, ura3-52, leu2-1, 
his3∆200, trp1::hisG, lys2::hisG) (Saha et al., 1993).Yeast cells were made competent 
using the lithium acetate method as stated in Ausubel et al (2006). Cells were kept at 
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4oC for a maximum of two weeks. Small-scale transformation of plasmids into the 
competent yeast cells were as follows: 0.5µg of plasmid was added to 2µl of fish sperm 
carrier DNA, followed by 10µl of competent cells (NLY2 with pCup1-hSkp1-Cub-
RUra3) and 50µl 40% PEG solution. The solutions were vortexed to ensure mixing, and 
incubated at 28oC for 1 hour. Subsequently, the tubes were heat-shocked in a 42oC 
water bath for 15 minutes. Next, the cells were pelleted by spinning at 7000rpm for 1 
minute; the pellet was resuspended in 20µl of sterile water, and plated onto a suitable 
selection plate. 
The screening of cDNA for interacting partners of hSkp1-Cub-RUra3 required 
large-scaled transformation. Here, 200µl of cDNA library fused downstream of Nub was 
added to 100µl of fish sperm carrier DNA. 200µl of competent cells (NLY2 + hSkp1-
Cub-RUra3) were added next, followed by 400µl of 40% PEG. The cells were vortexed 
before incubation at 28oC for an hour, and subsequently subjected to heat shock.  The 
cells were then pelleted by spinning at 7,000rpm for 1 minute; the pellet was 
resuspended in 4ml of sterile water, and spread on 7 plates plate lacking tryptophan and 
leucine (W-L-, termed WL) and containing 5-fluororotic acid (5-FOA) (F-W-L-; denoted 
FWL plate) and 7 FWL plates containing 100mM copper sulphate, labeled as 100FWL. 
The plates were incubated at 28oC for 3 to 10 days, and were checked for colonies 
regularly. 
 
3.4.2 Plasmid recovery and electroporation 
 The plasmids were recovered from yeast cells using the phenol-chloroform 
extraction method (Ausubel et al, 2006). The plasmids were then introduced into E. coli 
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DH10B cells through electroporation (BioRad, MicroPulserTM) using 4µl of plasmid 
with 40µl of E. coli cells. After recovery for 1 hour at 37oC, the cells were plated onto 
selective media LB plates containing chloramphenicol. Alkaline lysis miniprep was 
then carried out to isolate the plasmids from E. coli cells as described above. 
 
3.4.3 Droplet assay 
In a 96-well plate format, ten-fold serial dilutions of yeast cells were carried out to 10-5 
dilutions using a multi-pippetter. The total volume per well was 100µl. 5µl of the cells 
were plated onto the following plates: plates depleted of tryptophan and leucine (WL), 
uracil depleted plates (U-W-L-; termed UWL) and the WL plates with 5-fluoroorotic 
acid (5-FOA) added (labeled as FWL). Two other plates each had 100µM copper 
sulphate (CuSO4) added; as such they are labeled as 100FWL and 100UWL plates. 




























4.1 Cloning of inserts into yeast vectors and mammalian vectors 
 
 Polymerase chain reaction (PCR) was carried out to obtain the open reading frame 
(ORF) of hSKP1 and hSRB7, and the PCR products were subjected to electrophoresis to 
analyze the amplified products. The expected sizes of each product are shown in Table 1, 
and Figure 10a shows the PCR sample after electrophoresis. Restriction digestions of 
PCR products and of plasmids were carried out, and ligation was performed. 
Subsequently, DNA minipreparations by alkaline lysis were carried out to recover the 
plasmids, and restriction digestion as well as gel electrophoresis was carried out to check 
if the transformants carried the insert of the right size. Figure 10b shows the inserts for 
mammalian vectors cDNA3-hSrb7-Cub-RGpt2 and cDNA3-NubI2-hSkp1. The cloning of 
pCup1-hSrb7-Cub-RUra3 and pACNX-NubI2-hSkp1 was also successful. Next, DNA 
sequencing was performed to verify that the inserts were cloned in the right reading 
frame and there were no mutations. No mutations were observed in hSkp1 and hSrb7 and 
the inserts were cloned in frame with Nub and Cub respectively for both yeast and 
mammalian vectors (Refer to Appedice 3 and 4 for sequencing results). Cloning of 



























4.2 Interaction of hSrb7-Cub-RUra3 and Nub-hSkp1 in yeast 
 PCup-hSrb7-Cub-RUra314 was transformed into the yeast strain NLY2, and 
transformants were selected on plates lacking tryptophan (W-, designated W).  pACNX-
Nub-hSkp1 was then introduced into the above yeast strain, and selected on plates lacking 
tryptophan and leucine (W-L-, termed WL). The strength of the interaction between the 
 















Lane:  1        2       3       4       5 Figure 10b: Analysis of pcDNA3-hSrb7-Cub-
RGpt2 and pcDNA3-NubI2-hSkp1 
constructs. 
The DNA bands were stained with ethidium 
bromide and viewed under UV. Lane 1 shows the 
100bp DNA ladder. Lane 2 is the pcDNA3-Srb7-
Cub-RGpt2 plasmid that has been subjected to 
restriction digestion with HindIII and XhoI, and the 
expected sizes are 5701 bp (plasmid back bone) 
and 487 bp (insert). Lane 3 is the negative control 
pcDNA3-Cub-RGpt2 vector that has been cut with 
HindIII and XhoI. In lane 4, pcDNA3-Nub-Skp1 has 
been digested with enzymes HindIII and XbaI, and 
the expected sizes are 5352bp (plasmid back bone) 
and 663bp (insert). As for lane 5, it is the empty 
vector pcDNA3-Nub that has been subjected to 
restriction digestion with HindIII and XbaI. 
 
Figure 10a: Analysis of hSrb7 and hSkp1 
PCR products.  
The DNA bands were stained with ethidium 
bromide, and viewed under UV. Lane 1 shows 
the 100bp DNA ladder, Lane 2 is the PCR 
product of the ORF of hSrb7, and Lane 3 is the 
PCR product of the ORF of hSkp1. The sizes of 
hSrb7 and hSkp1 are 435bp and 492bp 
respectively. 
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two fusion proteins was quantified using ten-fold serial dilutions of cells coexpressing the 
fusion proteins. The serial dilutions were dropped onto WL plates, media lacking uracil, 
tryptophan and leucine (U-W-L-, termed UWL), media lacking uracil, tryptophan and 
leucine and containing 100 µM copper sulphate (CuSO4) (100 UWL), media containing 
5-FOA and lacking tryptophan and leucine (F-W-L-, termed FWL) and media containing 
100µM CuSO4, 5-FOA and lacking tryptophan and leucine (100 FWL). Figure 11 shows 
the results obtained, co-transformants expressing Nub-hSkp1 and hSrb7-Cub-RUra3 
proteins did not grow well in media lacking uracil, but survived on media containing 5-
FOA. This indicated that protein-protein interaction between full-length hSrb7 and hSkp1 
was observed using the yeast split-ubiquitin system. 
    Interaction of hSrb7-Cub-RUra3 with Nub-hSkp1 
    
           WL    UWL 
          Nub-hSkp1          
          Nub            
 
      100 UWL    FWL 
          Nub-hSkp1           
          Nub            
 
      100 FWL 
          Nub-hSkp1  
         Nub   
 
Figure 11: Full-length hSrb7p interacts with full-length hSkp1p in S. cerevisiae.  
The ten-fold serial dilution of cells co-expressing the hSrb7-Cub-RUra3 and Nub-hSkp1 or Nub are 
shown above, with the serial dilutions in decreasing order from left (100) to right 10-5). The cells 
were spotted on media lacking tryptophan and leucine (termed WL; top left), additionally lacking 
uracil (UWL; top right), additionally lacking uracil with 100 µM CuSO4 (100UWL; middle left), 
containing 5-FOA (FWL; middle right) and containing 5-FOA with 100 µM CuSO4 (100 FWL; 
bottom left). The cells expressing the interacting proteins grew less well on UWL and 100 UWL 
plates, and displayed a stronger resistance to 5-FOA than the empty vector Nub. 
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4.3 Construction of HT1080HPRT-::hSrb7-CubRGpt2 cell line 
 The hSrb7-Cub-RGpt2 plasmid was transfected into HT1080HPRT- cell, and 
stable cell lines were selected by the zeocin resistance selection marker on the plasmid. 
After two weeks of incubation, sixteen independent cell lines (i.e. single colonies) 
containing hSrb7-Cub-RGpt2 were picked and an analysis of their phenotype was 
performed in the two different mediums: medium containing HAT, and medium 
containing 6-TG and zeocin. After two weeks of incubation, it was found that of the 
sixteen independent cell lines, two were HAT resistant and 6-TG sensitive, whereas the 
remaining 14 were HAT sensitive and 6-TG resistant. The expected phenotype of cell 
lines expressing the hSrb7-Cub-RGpt2 fusion was HAT resistant and 6-TG sensitive, 
which meant that two cell lines were stably transfected with hSrb7-Cub-RGpt2.  
 
4.4 Interaction of hSkp1 with hSrb7 in the mammalian split-ubiquitin system 
 Nub-hSkp1 was co-transfected into one of the two stable cell lines, and two 
independent cell lines were analyzed for its phenotype in medium containing HAT and 
G418, and in medium containing 6-TG and zeocin. Figure 12 shows the phenotype of 
cells observed when transfected with Nub and Nub-hSkp1, and this indicated that 
interaction between Nub-hSkp1 and hSrb7-Cub-RGpt2 was detected using the mammalian 


















































+  FCS  
+ 6TG 
+ Zeocin 
Figure 12: Interaction between hSrb7-Cub-RGpt2 and Nub-hSkp1 was observed using the 
mammalian split-ubiquitin system.  
Left column: An HT1080HPRT- cell line coexpressing hSrb7-Cub-RGpt2 and Nub was grown in 
DMEM +10% FCS (first line), in DMEM +10% +HAT +G418 (second line) or in DMEM +10%FCS 
+6-TG +Zeocin (third line). This cell line was observed to be HATR and 6TGS. Right column: 
HT1080HPRT- cell line coexpressing hSrb7-Cub-RGpt2 and Nub-hSkp1 grown in the different 
selection media as described above. This cell line was observed to be HATS and 6TGR, indicating that 
hSrb7-Cub-RGpt2 and Nub-hSkp1 interacts.
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4.5 Analysis of knock-down of hSkp1 on inducible Hsp70B’ transcripts  
  The 19-nucleotide target against the 3’ UTR region of the hSkp1 mRNA was 
determined. Based on  the pSuper RNAi system, two 60-nucleotide long oligo were 
designed. Upon annealing of the two oligos, the double-stranded oligo was ligated into 
the pSuper vector that was cleaved with HindIII and SalI. Next, the vector was 
transformed into E. coli and alkaline lysis was performed. Figure 13 shows the results 


















Knock-down experiment of hSkp1 was performed, and Western blot with anti-hSkp1 






Figure 14: Analysis of the effects of hSkp1 siRNA on hSkp1p in HeLa cells. 
The Western blot was performed using antibodies against hSkp1p, and the expected size of the 
protein was 19kDa. Lane 1 shows the untransfected HeLa cells. In lanes 2, 3 and 4, HeLa cells 
have been transfected with 1ug, 2ug and 4ug of pSuper-hSkp1 681 respectively. 
Lane        1                 2              3              4 













Lane     1             2             3 Figure 13: Analysis of pSuper-681-hSkp1 
siRNA construct after restriction digestion 
and gel electrophoresis.  
The DNA bands have been stained with ethidium 
bromide and were viewed under UV. Lane 1 
shows the 100bp DNA ladder. In lane 2, the 
plasmid pSuper-681-Skp1 has been subjected to 
restriction digestion with EcoRI and XhoI to give 
two DNA bands of 4353bp (plasmid back-bone) 
and 287bp (insert). This indicated that the 
cloning of the target sequence into the vector was 
successful. Lane 3 shows restriction digestion 
product of empty vector pSuper with the same 
enzymes. The expected size is 4353bp (plasmid 
back bone) and 248bp. 
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 A different approach, the two-step reverse transcription polymerase chain reaction 
(RT-PCR) was carried out to verify the knockdown of hSkp1. Reverse transcription was 
first carried out, and real-time PCR using SYBR-Green was performed next. The 
expected amplicon size was 206 base pairs. Relative expression levels of hSkp1 mRNA 
in siRNA-treated samples and untreated samples were determined using the comparative 
threshold (CT) method. The fold change in the RNA expression between siRNA treated 
and untreated cells were calculated using the 2-∆∆CT method, with the human 
glyceraldehyde-3-phosphate dehydrogenase (GAPD) as an endogenous reference. The 
data of the quantitative analysis is shown in Table 6, and Figure 15a shows the results as 
a chart. 
 From Figure 15a, it was observed that hSkp1 siRNA was able to reduce the hSkp1 
transcript levels by 2-fold as compared to untreated cells. The induction of cells with heat 
had no effects on the mRNA levels of hSkp1, and any differences observed in the levels 
of hSkp1 transcripts was due to the treatment of cells with hSkp1 siRNA. For the same 
samples, the relative quantitation of Hsp70B’ RNA was also analyzed. This was to find 
out the effects of hSkp1 siRNA and heat induction on its mRNA. The results were 






Table 6: Relative quantitation of hSkp1 mRNA using the comparative CT method. 
Untreated cells refer to HeLa cells that were not treated with hSkp1 siRNA, but with the empty pSuper vector. HeLa cells that have 
been treated with siRNA against hSkp1 were labeled ‘Treated’. NHS: Non heat-shocked cells; HS: cells induced with heat at 42oC for 
15 min. After an hour of recovery at 37oC, the cells were then harvest for the isolation of total RNA. 
 
a. The ∆CT value is determined by subtracting the average GAPD CT  value from the average hSkp1 CT value. The standard deviation 
of the difference is calculated from the standard deviations of the hSkp1 and GAPD values, according to the following formula s √ s12 
+ s22 where s = standard deviation. 
b. The calculation of ∆∆CT involves subtraction by the ∆CT  calibrator value. This is the subtraction of an arbitrary constant, so the 
standard deviation of ∆∆CT is the same as the standard deviation of the ∆CT value. 
c. The range given for Skp1 relative to untreated NHS is determined by evaluating the expression: 2 -∆∆CT with ∆∆CT + s and ∆∆CT – 
s, where s = the standard deviation of the ∆∆CT value. 
 






CT - CT, Untreated NHSb 
hSkp1 
Rel to Untreated 
NHSc 
Untreated, NHS 25.92 ± 0.17 17.39 ± 0.03 8.53 ± 0.17 0 ± 0.17 1.0 (0.88, 1.12) 
Untreated, HS 25.63 ± 0.00 17.11 ± 0.08 8.52 ± 0.08 -0.01 ± 0.08 1.0 (0.95, 1.06) 
Treated NHS 27.00 ± 0.12 17.40 ± 0.09 9.60 ± 0.14 1.07 ± 0.14 0.47 (0.43, 0.52) 





Table 7: Relative quantitation of Hsp70B’ mRNA using the comparative CT method. 
Untreated cells refer to HeLa cells that were not treated with hSkp1 siRNA, but with the empty pSuper vector. HeLa cells that have 
been treated with siRNA against hSkp1 were labeled ‘treated’. NHS: Non heat-shocked cells; HS: cells induced with heat at 42oC for 
15 min. After an hour of recovery at 37oC, the cells were then harvest for the isolation of total RNA. 
 
a. The ∆CT value is determined by subtracting the average GAPD CT  value from the average Hsp70B’ CT value. The standard 
deviation of the difference is calculated from the standard deviations of the Hsp70B’ and GAPD values, according to the following 
formula s √ s12 + s22 where s = standard deviation. 
b. The calculation of ∆∆CT involves subtraction by the ∆CT  calibrator value. This is the subtraction of an arbitrary constant, so the 
standard deviation of ∆∆CT is the same as the standard deviation of the ∆CT value. 
c. The range given for Hsp70B’ relative to untreated NHS is determined by evaluating the expression: 2 -∆∆CT with ∆∆CT + s and 
∆∆CT – s, where s = the standard deviation of the ∆∆CT value. 
 






CT - CT, Untreated NHSb 
Hsp70B’ 
Rel to Untreated NHSc 
Untreated, NHS 29.95 ± 0.00 17.39 ± 0.03 12.56 ± 0.03 0 ± 0.03 1.0 (0.98, 1.02) 
Untreated, HS 21.60 ± 0.00 17.11 ± 0.08 4.49 ± 0.08 -8.07 ± 0.08 268.0 (254, 284) 
Treated, NHS 29.56 ± 0.08 17.40 ± 0.09 12.16 ± 0.12 -0.4 ± 0.12 1.3 (1.21, 1.43) 
Treated, HS 23.88 ± 1.20 17.24 ± 0.01 6.64 ± 1.20 -5.92 ± 1.2 60.5 (26.9, 139.1) 
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Figure 15a: Reduction in hSkp1 RNA levels was observed using the hSkp1 siRNA.  
The bar chart was constructed from the data stated in Table 6. Total RNA was isolated from the 
cells, and hSkp1 transcript levels were analyzed by reverse transcription and real-time PCR.   
 









































Figure 15b. Reduction in hSkp1 RNA levels reduced the activated Hsp70B’ RNA. 
The bar chart was constructed from the data stated in Table 7. Total RNA was isolated from cells 
and Hsp70B’ transcript levels were analyzed by reverse transcription and real-time PCR. 
 
Untreated cells refer to HeLa cells that were not treated with hSkp1 siRNA, but with the empty 
pSuper vector. HeLa cells that have been treated with siRNA against hSkp1 were labeled as 
‘Treated’. The relative expression level of Hsp70B’ RNA in each sample, with respect to 
untreated NHS sample, is provided in the parathesis. NHS: Non heat-shocked cells; HS: cells 















 From Table 7 and Figure 15b, it was observed in HeLa cells that were not treated 
with hSkp1 siRNA (‘Untreated’), there was a 268-fold increase in the transcripts of 
Hsp70B’ upon heat induction as compared non-heat shocked cells. This was as expected. 
The Hsp70B’ mRNA of NHS cells treated with hSkp1 siRNA (‘Treated, NHS’) were 
similar to the untreated NHS cells.  
 However, for the sample that was subjected to heat-induction and treatment with 
hSkp1 siRNA (Figure 15b, designated ‘Treated, heat-shocked’), there was only a 60-fold 
increase in the Hsp70B’ transcript levels as compared to the untreated NHS sample. 
These results indicated that there was a significant decrease of Hsp70B’ mRNA as 
compared to the heat-induced sample that had the wild-type levels of hSkp1 transcript 
(‘untreated, heat-shocked’). These results suggested hSkp1p was required for maximal 
induction of Hsp70B’ transcripts. 
 
4.6 Construction of a human cDNA library fused to Nub  
 Total RNA was isolated from four 75 cm2 flask of HeLa cells, and some of the 
total RNA from each flask was subjected to denaturing agarose gel electrophoresis and 







Figure 16: Formaldehyde 
agarose gel of total RNA 
isolated from four flasks of  
HeLa cells using the RNeasy 
Kit.  
The rRNA bands were stained with 
ethidium bromide and viewed under 
UV. The sizes for the human 18S 
rRNA is 1.9 kb, and the 28S rRNA is 
5.0 kb. The sizes of the RNA ladder, 




 Next, mRNA isolation was performed, followed by the first strand synthesis using 
NotI primer-adapter in the reverse transcription reaction. The second strand reaction was 
then carried out. The last step in the cDNA synthesis procedure was to ensure that the 
termini of the cDNA were blunt-end by using the T4 DNA polymerase. SalI adapters 
were added to the blunt-end double stranded cDNA, and the SalI-adapted cDNA was 
subjected to restriction digestion with NotI enzyme. Purification was performed next to 
remove the restriction enzymes and any unligated adapters, and the purified cDNA with 
SalI-NotI termini were then ligated to the SalI-NotI digested pACNX-Nub vectors in the 
three reading frames. A small-scale transformation was carried out to ascertain the 
number of clones, and cells were diluted 10-3, 10-4 and 10-5 times in LB and plated. A 
total of 40 colonies were obtained on the sector plated with transformants diluted 10-4 
times, and therefore the estimation of the total number of independent colonies was 4 x 
105. DNA minipreparations of twenty colonies were performed to find out the proportion 
of vectors with cDNA inserts and six plasmids of a total of twenty plasmids were 
observed to contain an insert. The cDNA insert sizes ranged from 300bp to 1000bp. 
Therefore it was estimated that 30% of the 4 x 105 colonies had an insert (1.2 x 105). The 
remainder of the ligation sample was concentrated by ethanol precipitation, and 
electroporation was carried out to introduce the plasmids into competent DH10B 
Escherichia coli cells. 
 
4.7 Screening of a human cDNA library fused to Nub using hSkp1-Cub-RUra3 as 
a bait 
 
 hSkp1 was cloned into the yeast vector Pcup1-Cub-RUra314 upstream of the Cub. 
Following the Cub is the uracil gene whereby the first amino acid has been replaced by an 
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arginine. Thus for the fusion Cub-RUra3, uracil prototrophy was an indication that the 
plasmid was successfully transformed into the yeast, and that it was expressed and 
functional. This plasmid contained a TRP1 gene, giving rise to tryptophan prototrophy 
when transformed into yeast cells. Therefore, yeast cells transformed with the Cub 
plasmid were plated onto media lacking tryptophan (W-).  
 ySgt1p (suppressor of G2 allele of Skp1) was shown to interact with ySkp1p in 
vitro and in vivo (Kitagawa et al., 1999), and here, the human homologs were used to see 
if the protein pair interact in S. cerevisiae. PCR and cloning were performed to clone the 
ORF of hSGT1 into the yeast vector pACNX-Nub to obtain the fusion protein of Nub-
hSgt1. As hSkp1p has been shown to be capable of forming dimers (Ng et al., 1998), Nub-
hSkp1 was also tested in the protein-protein interaction assay (Figure 17). Interaction 
between Nub-hSgt1 and Nub-hSkp1 with hSkp1-Cub-RUra3 was observed based on that 
the poor growth of the respective double transformants on plates lacking uracil, and 












Interaction of Nub-hSgt1 and Nub-hSkp1 with hSkp1-Cub-RUra3 
 
                    WL                    UWL 
        Nub-hSgt1           
        Nub-hSkp1            
        Nub               
 
           100 UWL       FWL         100 FWL 
       Nub-hSgt1                
       Nub-hSkp1               
       Nub                 
Figure 17: Nub-hSgt1 and Nub-hSkp1 interacts with hSkp1-Cub-RUra3 in S. 
cerevisiae.  
The ten-fold serial dilution of cells coexpressing hSkp1-Cub-RUra3 and Nub-hSkp1 / Nub-hSgt1 / 
Nub are shown above, with the serial dilutions in decreasing order from left (100) to right 10-5). 
The cells were spotted on media lacking tryptophan and leucine (termed WL; top left), 
additionally lacking uracil (UWL; top right), additionally lacking uracil with 100 µM CuSO4 (100 
UWL; middle left), containing 5-FOA (FWL; middle right) and containing 5-FOA with 100 µM 
CuSO4 (100 FWL; bottom left). The cells expressing the interacting proteins grew less 
well on UWL and 100 UWL plates, and displayed a stronger resistance to 5-FOA than 
the empty vector Nub. 
 
 
 Since hSkp1-Cub-RUra3 construct was shown to be enzymatically active, the next 
step was to screen the Nub-cDNA library fusion proteins to isolate interacting partners of 
hSkp1. The hSkp1-Cub-RUra3 plasmid was transformed into competent NLY2 cells, and 
the cells containing the Cub fusion vector were then transformed with the Nub-cDNA 
fusion plasmids to test for protein-protein interactions. WL plates with the addition of the 
drug 5-fluoro-orotic acid (5-FOA; termed FWL), and such plates with the addition of 100 
µM CuSO4 (100 FWL) were used to select for yeast cells containing both the interacting 
Cub and Nub protein in the yeast split-ubiquitin assay. As the plasmid containing the Cub-
RUra3 gene was driven by the CUP1 promoter, increased expression of the fusion protein 
was induced when CuSO4 was added. Cells were also plated onto WL plates as a positive 
control to find out the total number of colonies that were successfully transformed. The 
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plating was carried out in dilutions of 10-3, 10-4 and 10-5, and 50 colonies were obtained 
for 10-5 dilution. This indicated that the primary number of independent transformants 
was 5 x 106. A total of 14 colonies were obtained on the FWL and the 100 FWL plates 
after ten day incubation at 28oC. 
 These 14 colonies were then isolated from yeast via yeast breaking and amplified 
in E. coli. Two colonies were picked from each of these 14 samples, and restriction 
digestion was carried out to investigate the sizes of the inserts. Only six of the clones 
contained an insert, and these are candidate numbers 4.2, 7.1, 9.1, 12.1, 13.2 and 14.1. 
Next, these six Nub fusion plasmids were re-introduced into the NLY2 yeast strain 
containing the hSkp1-Cub-RUra3 plasmid to test for plasmid linkage. The strength of the 
interaction between the two fusion proteins was quantified using ten-fold serial dilutions 
of cells coexpressing the fusion proteins. The serial dilutions were dropped onto WL, 
UWL, 100 UWL, FWL and 100 FWL plates. Figure 18 shows the growth of the cells on 
the various plates, and interaction between the Nub fusion proteins and hSkp1-Cub-RUra3 
was observed. 
 Although the growth of cells can be seen on the plates after titration, there was a 
need to compare the growth of these cells relative to the negative controls to eliminate 
any background signals on each plate. Tim-Cub-RUra3 was used as a negative control as 
it was localized to the cytoplasm rather than the nucleus, and the interaction of the Nub 
fusion proteins with it is shown in Figure 18. This allowed one to see if the interaction 
observed between the Nub fusion proteins and hSkp1-Cub-RUra3 was specifically due to 
hSkp1 and not the Cub portion. The Nub expression vector pACNX-NubIBC1 was used as a 
negative control when testing interactions with hSkp1-Cub-RUra3 transformed  
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  Interactions of hSkp1-Cub-Rura3 with the Nub fusion proteins 
        
hSkp1-Cub-Rura3 
 
     Candidates                     
     4.2                     
 7.1             
 9.1             
 12.1             
 13.2             
 14.1             
 Nub             
 
 
 Figure 18: Ten-fold serial dilutions of cells co-expressing hSkp1-Cub-RUra3 and the various Nub fusion candidates were 
 spotted onto the various plates to compare the strength of Nub and Cub fusion protein interactions.  
 Serial dilutions were in decreasing order from left (100) to right (10-5). The lack of growth on uracil deficient plates and the 
 ability to grow on plates containing 5-FOA indicated protein-protein interaction. Nub empty plasmid was used as a negative 
 control. 
 
 WL: plates lacking tryptophan and leucine; UWL: plates lacking uracil, tryptophan and leucine; 100UWL: plates containing 
 100 µM CuSO4, and lacking uracil, tryptophan and leucine; FWL: plates containing 5-FOA and lacking tryptophan and 
 leucine; 100 FWL: plates containing 100 µM CuSO4, 5-FOA and lacking tryptophan and leucine 
  
WL UWL 100 UWL FWL 100FWL
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   Interaction of Tim-Cub-Rura3 with Nub fusion proteins 
 
Tim-Cub-Rura3       
 
       Candidates 
4.2                                        
7.1                      
9.1                         
12.1                       
13.2                       
14.1                       
            Nub                        
 
 Figure 19: Ten-fold serial dilutions of cells coexpressing Tim-Cub-RUra3 and the various Nub fusion candidates were 
 spotted onto the various plates to compare the strength of Nub and Cub fusion protein interactions.  
 Serial dilutions were in decreasing order from left (100) to right (10-5). The lack of growth on uracil deficient plates and the 
 ability to grow on plates containing 5-FOA indicated protein-protein interaction. Nub empty plasmid was used as a negative 
 control. 
 
 WL: plates lacking tryptophan and leucine; UWL: plates lacking uracil, tryptophan and leucine; 100 UWL: plates containing 
 100 µM CuSO4, and lacking uracil, tryptophan and leucine; FWL: plates containing 5-FOA and lacking tryptophan and 
 leucine; 100 FWL: plates containing 100 µM CuSO4, 5-FOA and lacking tryptophan and leucine. 
 
WL UWL 100 UWL FWL 100 FWL
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cells. This was to check for any background 5-FOA resistance that was not due to Cub and 
Nub fusion protein interaction.  
 The interaction between hSkp1-Cub-RUra3 and the six Nub-fusion plasmids, and 
Tim-Cub-RUra3 and the six Nub-fusion plasmids were quantified to allow comparisons 
with the negative controls and eliminate any background readings. Each of the double 
transformants was assigned a value from zero to six based on substantial growth of their 
serial diluted cells. For instance, when growth was seen for all six serial dilutions, this 
was designated a score of six. Conversely, if no growth was observed for all six serial 
dilutions, the value assigned would be zero. The values obtained here are termed the raw 
scores. Subsequently, these values were converted to relative scores when the 
background signals were taken into consideration. Formulae to calculate were as follows: 
 
 
Using Tim-Cub-RUra3 / candidate 4.2 co-transformant as an example, the relative 
interaction score on the UWL plate was: (5-2) – (4-3) = 2. 
As for the FWL plates, the formula used was as stated below: 
 
For instance, the relative score of Tim-Cub-RUra3 / candidate 4.2 co-transformant on the 
FWL plate was: (1-5) – (0-4) = 0. 
[(Score of double transformants on WL) – (Score of double transformant on UWL)] – 
[(Score of Nub on WL) – (Score of Nub on UWL)] 
 [(Score of double transformants on FWL) – (Score of double transformant on WL)] – 
[(Score of Nub on FWL) – (Score of Nub on WL)] 
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With the relative scores, an average score of the various Nub fusion proteins interacting 
with hSkp1-Cub-RUra3 was calculated; this score was obtained by taking an average of 
the relative scores of the four plates: 
 
In order to eliminate any non-specific background growth with unrelated proteins, the 
average relative score for each double transformant was obtained by subtracting the 
average score of Tim-Cub-RUra3 with the corresponding Nub fusion protein. Using 
hSkp1-Cub-RUra3 / candidate 4.2 as an example, the average relative score was obtained 
by the following formula: 
 
hSkp1-Cub-RURa3 / candidate 4.2 Final score = (hSkp1-Cub-RUra3 / candidate 4.2 
Average score) – (Tim-Cub-RUra3 / candidate 4.2 Average score) 
 
Thus the final score for hSkp1-Cub-RURa3 / candidate 4.2 was (2.75 – 0.75) = 2. The 
interaction scores of the split-ubiquitin assay between Tim-Cub-RUra3 and hSkp1-Cub-
RUra3 and the various Nub plasmids with inserts are listed in Table 8a and b respectively. 
These six Nub fusion plasmids were sequenced and subjected for BLAST search to 
identify the genes. The identities of genes from the cDNA library screen were listed in 
Table 9. 
 The expected protein sizes of each of the Nub fusion proteins were also calculated 
(Refer to Table 9), and these plasmids were transformed into the NLY2 yeast strain to 
test for the expression of the fusion proteins. The Western blot was performed using an 
Average score = (Relative score of UWL + Relative score of 100UWL + Relative score of 
FWL + Relative score of 100 FWL) / 4 











antibody against the haemagglutinin (HA) tag present between the Nub and the protein. 
Figure 20 shows the results of the Western blot analysis. 
 
    
Figure 20: Expression of Nub fusion proteins isolated from the library screen. 
Yeast cells were transformed with the various plasmids and harvested from media deficient in 
leucine for the SDS-PAGE. Western Blot analysis was performed using haemagglutinin primary 
antibody. Lane 1 and 2: expression of candidate 4.2 and 12.1 (Nub-Cdk2-interacting protein; 
32kDa), Lane 3: expression of candidate 7.1 (Nub-putative translation initiation factor (SUI1); 
21kDa), Lane 4: expression of candidate 9.1 (Nub-hypothetical protein FLJ14346; 22kDa), Lane 
5: candidate 13.2 (Nub-S100A6; 19kDa), Lane 6: 14.1 (Nub-S100A11; 21kDa) and Lane 7: 
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Relative score Candidate 










4.2 5 2 3 1 1 2 1 0 0 0.75 
7.1 5 2 2 2 2 2 2 1 1 1.5 
9.1 5 0 0 2 2 4 4 1 1 2.5 
12.1 5 1 2 2 2 3 2 1 1 1.75 
13.2 5 1 1 2 2 3 3 1 1 2 
14.1 4 1 1 2 2 2 2 2 2 2 
Nub 4 3 3 0 0 - - - - - 






Relative score Candidate 













4.2 5 1 3 4 2 3 2 4 2 2.75 2 
7.1 5 3 4 3 2 1 1 3 2 1.75 0.25 
9.1 5 2 4 4 3 2 1 4 3 2.5 0 
12.1 5 1 4 4 2 3 1 4 2 2.5 0.75 
13.2 5 2 4 3 1 2 1 3 1 1.75 0 
14.1 5 1 3 3 1 3 2 3 1 2.25 0.25 
Nub 5 4 5 0 0 - - - - - - 
Table 8(b): Strength of interactions between hSkp1-Cub-RUra3 and the Nub fusion 
candidates 
 
Table 8: Growth scores of the interactions between the various Cub fusions and the 
Nub fusion candidates.  
Raw scores (ranging from 0 to 6) were assigned by counting the number of serial 
dilutions where growth was observed. The Cub fusion protein average score was obtained 
by taking the average of the calculated scores, and the final score was calculated by 
taking the respective Cub fusion protein average score subtracting the Tim-Cub-RUra3 
average score.  
 
WL: plates lacking tryptophan and leucine 
U: plates lacking uracil, tryptophan and leucine 
100U: plates containing 100µM CuSO4, and lacking uracil, tryptophan and leucine 
FWL: plates containing 5-FOA and lacking tryptophan and leucine 











Results of Blast from 




Is the ORF intact? Western Blot (HA tagged) 
4.2  2 1500 Yes, frame 2 
12.1  
 0.25 1500 
Homo sapiens cyclin-
dependent kinase 2-
interacting protein (CINP) Yes, 
frame 2 
1st  Met missing. The 3’ 
untranslated region is 
different between the two 
clones. 
Yes. 31 kDa as 
expected. 
7.1  0 650 
Homo sapiens putative 




Has some 5’ untranslated 
region. ORF is intact. 
Yes. 21 kDa as 
expected. 
9.1  0.75 850 Homo sapiens hypothetical protein FLJ14346, mRNA 
Yes, 
frame 1 
First 12 amino acids 
missing, replaced by 3 
repeats of HASA. 
Yes. 22 kDa as 
expected. 
13.2  0 850 
Homo sapiens S100 calcium 




Has some 5’ untranslated 
region. ORF is intact. 
Yes. 19kDa as 
expected. 
14.1  0.25 500 
Homo sapiens S100 calcium 





Has some 5’ untranslated 
region. ORF is intact. 
Yes. 21 kDa as 
expected. 
      
Table 9: Identification of genes of the Nub fusion inserts sequences from the library screen.  
The description of the various candidates isolated from the library screen that had an insert. The length of insert was observed from the 
restriction digestion with enzymes Hind III and Not I, and includes Nub. Final score referred to the interaction strength of the protein pair, 
and nucleotide BLAST search was performed to identify the insert. Western Blot was also performed to verify the sizes of the Nub fusion 
proteins. The frame indicated refers to the reading frame that the insert was cloned downstream to Nub. ORF: open reading frame; HA: 
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5. Discussion 
5.1 Interaction between hSrb7p and hSkp1p observed in yeast and human cells 
 
 According to the Morley (2003), a C-terminal portion of hSkp1p was isolated in a 
yeast split-ubiquitin system using hSrb7p as bait. In this first part of my thesis, I have 
verified that full-length hSrb7p and full-length hSkp1p indeed interact in both the yeast 
and mammalian split-ubiquitin system.  
 
5.1.1 Molecular cloning 
 The generation of the open reading frame (ORF) of hSKP1 and hSRB7 via PCR 
was successful (Figure 10a), and by designing the PCR primers such that they contain the 
appropriate restriction sites at each end, cloning into the various vectors was made 
possible. The ORFs were subjected to restriction digestion and then subjected to column 
purification to remove the enzymes. For the yeast vectors, the ORF of hSkp1 was cloned 
into pACNX-Nub vectors, resulting in the fusion protein Nub-hSkp1, whereas for hSrb7, it 
was cloned into Pcup-Cub-RUra3 and therefore giving rise to fusion protein Srb7-Cub-
RUra3. The ORF of hSkp1 was cloned into mammalian vector pcDNA3-NubI2, resulting 
in the fusion protein NubI2-hSkp1; as for hSrb7, it was cloned into pcDNA3-Cub-RGpt2 
vector thus ensuing that the final protein was hSrb7-Cub-RGpt2. DNA sequencing was 
performed to ensure that these ORF were cloned in the right reading frame with respect 
to Nub and Cub in order to obtain fusion proteins. It was also verified that there were no 
missense or nonsense mutations present in the clones. The cloning of plasmid pACNX-
NubI2-hSgt1 was successful as well. 
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5.1.2 Interaction of hSrb7-Cub-RUra3 and Nub-hSkp1 in S. cerevisiae using the 
yeast split-ubiquitin system 
 
 hSrb7 was cloned into yeast vector upstream of the Cub. Following the Cub is the 
uracil gene whereby the first amino acid has been replaced by an arginine. Thus for the 
fusion Cub-RUra3, uracil prototrophy was an indication that the plasmid was successfully 
transformed into the yeast, and it was expressed and functional. This plasmid also 
contains a TRP1 gene, therefore giving rise to tryptophan prototrophy when transformed 
into yeast cells. As such, yeast cells transformed with the Cub plasmid were plated onto 
plates lacking tryptophan (W-, designated W). pACNX-Nub-hSkp1 was then transformed 
into the above yeast strain. The Nub plasmid contains the LEU2 gene which confers 
leucine prototrophy to transformed yeast cells; both plasmids are selected for by plating 
the transformants on plates lacking tryptophan and leucine (W-L-, termed WL). 
Subsequently, the strength of the interaction between the two fusion proteins was 
quantified using ten-fold serial dilutions of cells co-expressing the fusion proteins. The 
serial dilutions were dropped onto five different media which would be discussed in 
detail below. 
 In the yeast split-ubiquitin system, protein interactions within the cell would result 
in increased local concentrations of the two halves of ubiquitin, and the formation of a 
native-like ubiquitin moiety. The RUra3p reporter would then be cleaved off by the 
ubiquitin-specific proteases (UBPs), and subsequently be degraded by enzymes of the N-
end rule of protein degradation. Therefore, these yeast cells would display an inability to 
grow on plates lacking uracil. Instead of using plates lacking just uracil, selection plates 
lacking uracil, tryptophan and leucine (U-W-L-, designated UWL) were used to ensure 
that both plasmids were maintained in the yeast cells.  As the plasmid containing the Cub-
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RUra3 gene was driven by the CUP1 promoter, increased expression of the fusion protein 
occurs when copper sulphate (CuSO4) was added. Therefore, yeast cells were also plated 
onto the UWL selection plates with 100µM CuSO4 (100UWL). In addition, the cells were 
also titrated onto plates containing 5-fluoro-ororatic acid, a drug counterselecting Ura3. 
The ability of yeast cells to grow on selection plates lacking tryptophan and leucine with 
the addition of 5-fluorooratic acid (designated FWL) and such plates with the addition of 
100µM CuSO4 (100FWL) indicated that the Ura protein had been degraded as a result of 
the protein-protein interaction, and therefore 5-FOA was no longer toxic to the cells. 
 In Figure 11, it was observed that cells co-expressing hSrb7-Cub-RUra3 and Nub-
hSkp1 showed little or no growth on UWL and 100UWL plates, an indication that the 
Ura3 enzyme was not present despite the selection for the Cub plasmid. On the contrary, 
the cells co-expressing hSrb7-Cub-RUra3 and Nub had abundant growth on the UWL and 
100UWL plates, suggesting that uracil prototrophy was still observed. As for the FWL 
and 100FWL plates, profuse growth was observed for cells co-expressing hSrb7-Cub-
RUra3 and Nub-hSkp1, but much less growth was observed for cells co-expressing hSrb7-
Cub-RUra3 and Nub empty vector. Taken together, these observations indicated that 
hSrb7-Cub-RUra3 and Nub-hSkp1 interacted in the yeast cells, and accordingly the native-
like ubiquitin molecule was formed. As a result, the RUra3 reporter was cleaved by the 
Ubps, and subsequently degraded by the enzymes of the N-end rule. Therefore these cells 
were not able to grow on media lacking uracil, but survived in media containing 5-FOA, 
since it was no longer toxic to the cells. As a positive control, cells were also plated onto 
plates lacking tryptophan and leucine (WL), and as expected, all the transformants grew 
well on this plate. In conclusion, the interaction of hSrb7-Cub-RUra3 and Nub-hSkp1 was 
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observed in yeast cells using the yeast split-ubiquitin system, which indicated that both 
full-length proteins could interact. 
 
5.1.3 Construction of stable HT1080HPRT-::hSrb7-Cub-RGpt2 cell line 
 Now that the interaction between hSrb7p and hSkp1p has been observed in yeast 
cells, I went on to investigate if the interaction between this pair of proteins would also 
be observed in human cells using the mammalian split-ubiquitin system (Rojo-Niersbach 
et al., 2000). It is important to verify that the protein-protein interaction is observed in 
mammalian cells because these two proteins should interact in their native environment. 
 HPRT enzyme activity is required for the phosphoribosylation of hypoxanthine 
and guanine, salvaging them for the biosynthesis of nucleic acids (Albertini, 2001). The 
enzyme Gpt2p from Escherichia coli is able to complement the deficiency of 
HT1080HPRT- cells. Thus the HT1080HPRT- cells that are stably transfected with the 
Cub vectors are expected to be resistant in medium containing HAT (HATR), and sensitive 
to medium containing 6-TG (6TGS). The sensitivity to medium containing 6-TG is due to 
the fact that the Gpt2p enzyme is able to phosphoribosylate the purine analogue 6-TG, 
and this step causes its cytotoxicity to the cells. On the other hand, these cells can survive 
in HAT medium as the GPT2 gene and the presence of hypoxanthine (a purine) in the 
medium allows for a functional salvage pathway for nucleotide synthesis. 
 hSrb7-Cub-RGpt2 was observed to be stably integrated into two HT1080HPRT- 
cell lines as seen by the phenotype of the cell line – resistance in medium containing 
HAT and sensitive to medium containing 6-TG and zeocin. The addition of zeocin which 
selected for the plasmid was important. This was because medium containing 6-TG 
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selected against the Cub vectors, and cells grown in this medium might have lost the 
plasmid in order to survive. As zeocin exerted a selection pressure on the cells to retain 
the plasmids, any cell line that is resistant in HAT, but sensitive in 6-TG with zeocin 
medium, is the ideal cell line that is expressing the Gpt2p. One of the key difficulties 
faced in the construction of a stable hSrb7-Cub-RGpt2 cell line was the isolation of single 
colonies after transfection. This step was critical as subsequent steps depended on the 
phenotype of the cells in various media to detect if there were any protein interactions. 
Different cell lines could have differently integrated plasmids, and picking more than a 
single colony would result in inconsistencies in the phenotype detected, giving rise to 
inaccurate results in later stages of the experiment.  
 
5.1.4 Interaction of hSrb7-Cub-RGpt2 and Nub-hSkp1 in HT1080HPRT- cells using 
 the mammalian split-ubiquitin system 
 
 The mammalian split-ubiquitin system differs from the yeast system in that the 
reporter protein used is the RGpt2 protein, where the first amino acid has been modified 
to an arginine. Should the protein fused to Cub-RGpt2 interact with the protein fused to 
Nub, a native-like ubiquitin would be reconstituted when the two halves of ubiquitin are 
brought into close proximity. This would result in the cleavage of the reporter protein 
RGpt2, and its degradation by the enzymes of the N-end rule. Thus the HT1080HPRT- 
cells co-expressing the two proteins that interact would revert to being deficient in the 
ability to salvage nucleotides. These cells would be sensitive to HAT but resistant to 6-
TG. For the construction of stable Nub cell lines, G418 had been added to the medium 
containing HAT. This was because HAT selected for the Cub plasmid while G418 selects 
for the Nub plasmid, ensuring that neither plasmid is lost. As for medium containing 6-
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TG, zeocin has been added as mentioned above. The co-expression of Nub alone acted as 
a negative control. 
 One of the hSrb7-Cub-RGpt2 cell lines was used for the transfection of Nub-hSkp1. 
Selection in the various media was carried out, and the observed phenotype is shown in 
Figure 12. It was observed that the cells co-expressing hSrb7-Cub-RGpt2 and just the Nub 
alone remained HATR and 6TGS, and this was as expected since Nub by itself does not 
interact with Cub. As for cells co-expressing hSrb7-Cub-RGpt2 and Nub-hSkp1, the 
phenotype was HATS and 6TGR; this indicated that interaction between hSkp1p and 
hSrb7p was observed. As these two proteins were brought into close proximities, a 
native-like ubiquitin moiety was reconstituted, and thereby resulting in the cleavage of 
reporter protein RGpt2 and its degradation via the N-end rule. The degradation of Gpt2p 
caused the cells to now revert to HATS and 6TGR. To summarize this part of the 
discussion, the interaction of full-length hSrb7p and full-length hSkp1p was observed in 
human cells using the mammalian split-ubiquitin system.  
 Now that protein-protein interactions between the two proteins have been 
established, the next step was to understand the functions of hSkp1p with respect to its 
interaction with hSrb7p. The latter is a subunit in both the yeast and mammalian 
Mediator complex, and ySrb7p has been shown by Gromoller and Lehming (2000) to 
interact with the repressor Tup1p. As for hSkp1p, one of the best defined roles of this 
protein is as an adapter in the Skp1-Cullin-F-box (SCF) E3 ubiquitin ligase complex. It 
acts as a linker between the Cullin protein Cul1p and RING finger protein Hrt1p, and the 
F-box proteins as shown in Figure 4 (Zheng et al., 2002). The SCF ubiquitin ligase 
complex acts together with the E1 and E2 enzymes in the process of poly-ubiquitylation 
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of target proteins, resulting in their degradation via the 26S proteasome. However, 
ySkp1p also has roles either than as an adapter in the SCF ligases complex, for instance, 
ySkp1p has been shown to be involved in endocyctosis (Galan et al., 2001) and the 
formation of kinetochore complex (Kaplan et al., 1997). Most of the proteins that interact 
with Skp1p contain an F-box motif which binds to the C-terminal helical extension of 
Skp1p, and examples of such proteins include Grr1p in yeast and Skp2p in humans. But 
ySkp1 also interacts with proteins that lack an F-box motif, like Cul1p, Sgt1p, Rav1p and 
Rav2p; another indication that the role of Skp1p is not restricted to the SCF complex. As 
for Srb7p, it is not known to contain an F-box sequence motif.  
 Another intriguing point is that Skp1 has some homology to a transcriptional 
elongation factor (TCEB1), and was therefore termed TCEB1-L (Sowden et al. 1995). 
Incidentally, TCEB1 encodes for ElonginC, a eukaryotic transcription factor that is part 
of the SIII elongation complex. As discussed in Section 2.1.2 and 2.2.2, ElonginBC can 
assemble with Cul2p, Hrt1p and Med8p to reconstitute an ubiquitin ligase. Med8p is a 
component of the Mediator complex and possesses a conserved BC-box motif to which 
ElonginC binds. My work now suggests that another subunit of the Mediator complex, 
hSrb7p, interacts with hSkp1p which is a component of the SCF E3 ubiquitin ligase. 
Although Schulman et al. (2000) have shown that hSkp1p binds the F-box protein 
hSkp2p differently from the way ElonginC binds to BC-box protein von Hippel-Lindau 
(VHL), the arrangement of the helixes in the two interfaces are similar. However, one 
clear difference is the location of hMed8p and hSrb7p in the Mediator complex: hMed8 is 
located in the head domain of the Mediator complex whereas hSrb7p has been shown to 
localize to the Middle domain (Figure 1). Nonetheless, this could imply that hMed8p and 
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hSrb7p could recruit ubiquitin ligase activity to the Mediator or the holoenzyme, possibly 
leading to the poly-ubiquitylation of the target and its degradation by the 26S proteasome. 
The Mediator complex is already known to possess histone acetyl-transferase activity 
HAT through subunit Nut1p (Lorch et al., 2000). However, as NUT1 is a non-essential 
gene in yeast, HAT activity was not believed to be a major role of the Mediator complex. 
In this case, since SRB7 is an essential gene in yeast, this may imply that the E3 ubiquitin 
ligase activity may, indeed, play an important role for the Mediator complex.  
 
5.2 Skp1p is required for maximal induction of Hsp70B’ RNA 
5.2.1 The rationale behind the experiment 
 As discussed earlier, the interaction of hSrb7p and hSkp1p may bring the E3 
ubiquitin ligase activity to the Mediator complex. Alternatively, hSkp1p could act as a 
transcription factor since it is homologous to a transcriptional elongation factor. Thus I 
wanted to investigate the effects of hSkp1p on transcription. This part of the experiment 
encompasses finding an inducible transcription promoter and studying its transcript levels 
when hSkp1 mRNA levels are reduced using RNA interference.  
 Short-interfering hSkp1 RNA targeting the 3’ untranslated region (3’ UTR) of 
hSkp1 mRNA was produced using the pSuper RNAi system. The vector pSuper uses the 
polymerase III-H1 RNA gene promoter to produce a small RNA transcript which lacks a 
polyadenosine tail, and the transcript also has a well-defined transcription start site and a 
termination signal made up of 5 thymidines. It is predicted to fold back on itself to form a 
19-nucleotide pair stem-loop structure, and it is believed that such stem-loop precursor 
transcripts are then quickly cleaved in the cell to produce a functional siRNA. The human 
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Heat Shock protein 70 (HSP70) promoter was chosen as it is under selective and 
inducible transcriptional regulation that is well-studied in eukaryotes. Cells respond to 
temperatures above their optimum for growth by producing these heat shock proteins 
(with 70,000 kDa being the most prominent), and the response is rapid; within minutes of 
heat induction, transcription is initiated at the hsp gene loci. There are 4 known heat-
inducible Hsp70 genes in humans (Parisan et al., 2000), and the Hsp70B’ was selected 
because according to Parisan et al. (2000), the transcripts of this gene was strongly 
induced upon heat-induction. Because of its efficiency of induction of transcription, the 
heat-shock promoters, especially the hsp70 promoters, have been used for gene therapy 
strategies (Rome et al., 2005). 
 Two-step reverse transcription polymerase chain reaction (RT-PCR) using the 
SYBR-Green dye was employed to study the amounts of hSkp1 and Hsp70B’ RNA. 
Untreated HeLa cells referred to cells that were treated with empty vector pSuper, and 
not hSkp1 siRNA. On the other hand, treated cells referred to those transfected with 
hSkp1 siRNA. Forty-eight hours after transfection, the cells were then either subjected to 
heat-induction or non-heat shocked (NHS). Heat treatment referred to cells being placed 
at 42oC for 15 minutes; these cells then had a recovery period of an hour at 37oC. 
Subsequently, total RNA was harvest from all samples, and the transcripts of hSkp1 and 
Hsp70B’ were analyzed by reverse transcription and quantitative real-time PCR by 
SYBR-Green dye. The endogenous control used was the human glyceraldehyde-3-
phosphate dehydrogenase (GAPD).  
 Real-time PCR assays were used in this part of the experiment as I wanted to 
track the effects of reduction of hSkp1 on the activated transcription of Hsp70B’. This 
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assay is highly sensitive to difference in amount of starting sample, as compared to PCR 
where only the end products are analyzed. The SYBR-Green dye chemistry was used in 
the assay, and the dye binds to double-stranded DNA products formed during PCR. It 
was chosen instead of the TaqMan chemistry as the SYBR-Green could be used to 
monitor both the hSkp1 and Hsp70B’ RNA levels (in separate reactions). In addition, it 
does not require additional probes, therefore reducing costs. However, false-positive 
results may arise as SYBR-Green dye binds unspecifically to any double-stranded DNA 
sequences. Thus a dissociation (melting) curve was carried out at the end of the real-time 
PCR to ensure that there was no non-specific products formed during the run. At the 
melting temperature of the amplicon, only a single sharp peak was observed, and the non-
template control did not yield any fluorescence. In addition, the real time PCR was 
performed in duplicates to control pipetting errors. A non-template control where all the 
PCR reagents were added except the RNA template was included as a negative control; 
as expected, no fluorescence was detected for this sample. At the end of the run, relative 
quantitation by the comparative CT method was then used to analyze the changes in RNA 
levels of hSkp1 and Hsp70B’ relative to the sample that was not subjected to transfection 
with hSkp1 siRNA and non-heat induced (Figure 15, ‘untreated, NHS’).  
 
5.2.2 Discussion of the results 
 The cloning of the pSuper-681-hSkp1 plasmid was successful (Figure 13), and 
transfection of this plasmid into HeLa cells resulted in some reduction of hSkp1 protein 
levels (Figure 14). In the second part of the experiment, RT-PCR was performed for the 
various samples. Relative quantitation of the data using the comparative CT method was 
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carried out, and calculations are shown in Table 6 for analysis of hSkp1 mRNA and 
Table 7 for Hsp70B’ mRNA. The higher the starting copy number of the nucleic acid 
target, the sooner a significant increase in fluorescence can be detected; thus a smaller 
threshold cycle (CT) value indicates that fewer cycles are needed for the fluorescence to 
reach a fixed threshold level. 
 From Figure 15a, it was seen that the transfection of cells with hSkp1 siRNA had 
resulted in two-fold decrease in hSkp1 mRNA compared to untreated cells. Induction of 
cells with heat did not affect the hSkp1 transcripts in both untreated and treated cells. 
RNA interference using hSkp1 siRNA did not result in the elimination of hSkp1 
transcripts. One explanation for this could be that Skp1 is an essential gene in S. 
cerevisiae (Giaever et al., 2002), and it may be also be an gene required for cell viability 
in human cells. Therefore, the levels of Skp1 mRNA were not eliminated since the 
human cells would likely be dead if this protein was absent. 
 Next, the transcript levels of inducible Hsp70B’ gene was investigated. It was 
observed that for the untreated cells, upon heat-shock at 45oC for 15 minutes, there was a 
significant increase in the Hsp70B’ mRNA levels as compared to the non-heat shocked 
(NHS) cells (Refer to the data in Table 7 and Figure 15b). The 217-nucleotide amplicon 
increased 268-fold in the heat-shocked sample compared to NHS cells. This was as 
expected as many articles have reported that cells respond within minutes of rise in 
temperature to produce heat-shock proteins. The transfection of hSkp1 siRNA in NHS 
cells did not have an effect on the Hsp70B’ basal level. This was an important control to 
show that the hSkp1 siRNA does not affect the Hsp70B’ transcripts. However, when the 
cells were treated with hSkp1 siRNA and induced with heat, there was only a 60-fold 
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increase in Hsp70B’ transcripts as compared to the NHS hSkp1 siRNA-treated sample. In 
a comparison between the two heat-shocked samples, the sample that was treated with 
hSkp1 siRNA resulted in a 4-fold decrease in Hsp70B’ transcript versus the sample that 
was untreated. In conclusion, the reduction of hSkp1 had reduced the transcripts levels of 
induced Hsp70B’ gene, indicating that hSkp1p is required for the maximal induction of 
Hsp70B’. 
 From these data, we can say that hSkp1p has a positive effect on induction of the 
Hsp70B’ RNA. Its interaction with hSrb7p could affect the holoenzyme in such a way 
that transcription initiated is activated. There are several possibilities as to how hSkp1p 
may act to increase the transcription efficiency of Hsp70B’. Given the increased evidence 
of the cross-talk between ubiquitin-proteasome pathway and transcription regulation, it is 
an attractive idea to postulate that the recruitment of hSkp1p to the promoter by hSrb7p 
would result in the attraction of the SCF E3 ubiquitin ligase, resulting in the poly-
ubiquitylation of transcription factors like repressors. With the degradation of the 
repressor, efficient transcription of Hsp70B’ mRNA would occur. This simplified model 
would imply that hSkp1 works at the transcription initiation level, and involves the SCF 
ligase. 
 Intriguingly, there is a possibility that hSkp1p may act at the transcription 
elongation stage and not the transcription initiation phase. As mentioned earlier, hSkp1p 
is homologous to Elongin C. The latter was first discovered together with Elongin B and 
Elongin A as part of the Elongin complex (SIII), and this complex was shown to 
stimulate the rate of elongation of RNAPII in mRNA synthesis (Bradsher et al., 1993a, 
b). However, the exact mechanisms of how the SIII complex affects elongation have not 
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been deduced up to this day. In this proposed model, hSkp1p would work independently 
of the SCF E3 ubiquitin ligase. It would be recruited to the holoenzyme by Srb7p, 
resulting in the enhancement of the transcription elongation ability of the RNAPII. This 
theory is similar to the work by Gerber et al. (2005). The expression of heat shock genes 
was believed to be regulated at the promoter clearance phase, and therefore the 
transcription of such genes are strongly affected by the recruitment of RNAPII elongation 
factors to the promoter. It was shown that in Drosophila melanogaster, dEloA, an 
Elongin A homologue, was involved in the regulation of heat shock gene. Should hSkp1p 
function as a transcription elongation factor, this could explain why a decrease in 
Hsp70B’ mRNA was detected when Skp1 transcripts decreased. 
 Another possible scenario is that hSkp1p may attract the SCF ligase complex, 
resulting in the ubiquitylation of a factor involved in transcription. This protein could 
range from a Mediator subunit, histones, RNA polymerase II or activators and repressors 
at the promoter region (Muratani and Tansey, 2003). This would be in accordance with 
the work by theory that the Elongin BC complex, together with BC-box containing 
Elongin A, was speculated to be responsible for the ubiquitylation of RNAPII or other 
transcriptional factors (Shilatifard et al., 2003). We now know that the large subunit of 
RNAPII becomes ubiquitylated when exposed to DNA damaging agents like UV, and the 
function of the ubiquitylation of RNAPII was to degrade it and allow the DNA repair 
machinery to be recruited to the site. However, the exact function of hSkp1p has not been 
elucidated, and more work remains to be carried out. 
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5.3 Cloning of complementary DNA (cDNA) library fused to Nub 
 The isolation of total RNA was successful as shown in the integrity and sizes of 
the ribosomal bands on the denaturing formaldehyde gel (Figure 16). Both the 18S and 
26S ribosomal RNA appeared as sharp bands when viewed under UV and this indicated 
that the RNA sample did not suffer any major degradation during the isolation. mRNA 
was isolated from the total RNA, and subsequently, the first strand and second strand 
synthesis of cDNA was performed. The resulting cDNA was constructed such that they 
had Sal I-NotI restriction sites generated at the 5’ and 3’ end for directional cloning into 
the Nub plasmids. After the ligation of cDNA to the vectors and transformation into E. 
coli cells, twenty colonies were picked for analysis of cloning efficiency. Of twenty 
plasmids, six were observed to contain an insert. Given that that total number of clones 
was estimated to be 4 x 105, this means that 30% of them carried an insert. Therefore I 
estimate that about 1.2 x 105 clones contain an insert, and only a third of these are 
expected to be in frame with Nub (4 x 104) to give rise to fusions with real proteins. 
 To create a library, one can choose to construct a genomic DNA (gDNA) library 
or complementary DNA (cDNA) library. The use of gDNA library may not be suitable 
for protein-protein interaction assays since it may contain non-coding sequences (introns) 
which have to be removed before the protein can be functional and fold into the right 
conformation. Thus, the library was constructed using cDNA isolated from HeLa cells. 
The SuperscriptTM plasmid system (Invitrogen) was chosen because it was able to 
produce a directional library instead of random library. This means that all the members 
in the cDNA library contain cDNA inserts cloned in a specific orientation relative to the 
transcriptional polarity of the original mRNAs; members of a random library will have 
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inserts in either orientation. As such, all members of the directional library have the 
potential the express a functional mRNA. However, as this library produces fusion 
proteins where the cDNA are cloned downstream of the Nub, only one-third of the 
members are expected to be in the right reading frame. The cDNA library should ideally 
contain all mRNA present in a cell to be representative. Because many mRNAs are only 
expressed in low levels – as little as 1 in 106 of total mRNA, the cloned cDNA library 
should contain at least 1 million clones. To improve the cloning efficiency of the cDNA 
library, I would propose performing column-size fractionation of the cDNA fragments 
before ligating them to the digested vectors. This removes inserts which are too small and 
may not give rise to functional proteins. This is because it has been noted that the smaller 
the insert fragment, the easier it is to clone into the plasmid. 
 
5.4 Nub-cDNA library screen using hSkp1-Cub-RUra3 as bait in the yeast split-
 ubiquitin system 
 
 hSkp1 was cloned upstream of Cub-RUra3, and it was important to ensure that the 
resultant fusion protein was functionally active. This was because there was a possibility 
that the protein was unable to fold into the right conformation due to steric hindrance. 
Yeast cells transformed with this plasmid had been shown to be able to grow on plates 
lacking uracil (U-), an indication that the Ura3 enzyme was active. In addition, ySgt1, a 
protein known to interact with ySkp1, and therefore the human protein pairs were tested 
if they would interact (Kitagawa et al., 1999). Here, hSgt1 was cloned downstream of 
Nub, therefore giving rise to fusion protein Nub-hSgt1. It was observed in Figure 17 that 
cells co-expressing hSkp1-Cub-RUra3 and Nub-hSgt1 did not grow very well on plates 
lacking uracil, but grew well on media containing 5-FOA. This indicated that hSkp1 and 
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hSgt1 indeed interact. As hSkp1 was also documented to be able to form dimers, Nub-
hSkp1 was used as a positive control. Similarly, cells co-expressing hSkp1-Cub-RUra3 
and Nub-hSgt1 exhibited poor growth on media lacking uracil, and abundant growth was 
observed on media containing 5-FOA. On the contrary, cells co-expressing hSkp1-Cub-
RUra3 and Nub (negative control) grew well on plates lacking uracil and did not survive 
on media containing 5-FOA. As previously discussed in Section 5.1.2, the interaction of 
two proteins would result in the cleavage and degradation of the reporter protein RUra3 
by the enzymes of the N-end rule. This means that the cells display uracil auxotrophy and 
resistance to 5-FOA should they co-express an interacting pair of proteins. Therefore, 
these phenotypes were an indication that Nub-hSkp1 and Nub-hSgt1 interacted with 
hSkp1-Cub-RUra3.  
 Subsequently, the yeast split-ubiquitin assay was used to find interacting partners 
of hSkp1 by screening the library of human cDNA fused downstream of Nub. The Nub 
library constructed was transformed into a yeast strain containing hSkp1-Cub-RUra314 
plasmid. The transformed cells were then plated onto WL, FWL, and 100 FWL like 
mentioned in Section 5.1.2. The plating of cells on the WL plate was carried out in 
dilutions of 10-3, 10-4 and 10-5, and 50 colonies were obtained on the 10-5 dilution. This 
meant that there were 5,000,000 independent primary transformants. Protein-protein 
interactions within the cell would result in increased local concentrations of the two 
halves of ubiquitin, and the formation of a native-like ubiquitin moiety. The RUra3p 
reporter would then be cleaved by the ubiquitin-specific protease (UBPs), and 
subsequently degraded by enzymes of the N-end rule of protein degradation. As such, the 
ability of yeast cells to grow on the selection plates FWL and 100 FWL indicated that the 
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Ura3 protein had been degraded, and therefore 5-FOA was no longer toxic to the cells. 
Fourteen yeast colonies co-expressing the Cub and Nub fusion proteins grew on the 
selection plates.  
 These 14 colonies were then subjected to yeast breaking, and the plasmids 
recovered were amplified in E. coli. The plasmids were subjected to restriction digestion 
to find out the sizes of the inserts (Table 9). As the plasmids that were of relevance to the 
library screen should carry an insert, thus only candidate 4.2, 7.1, 9.1, 12.1, 13.2 and 14.1 
were subjected to further tests. These six plasmids were tested for plasmid linkage to 
establish if they were indeed responsible for the change in phenotype observed on media 
lacking uracil and containing 5-FOA. The strength of the interaction between the two 
fusion proteins was quantified using ten-fold serial dilutions of cells co-expressing the 
fusion proteins. The serial dilutions were dropped onto WL, UWL, 100 UWL, FWL and 
100 FWL plates. Figure 18 shows the growth of the cells on the various plates, and cells 
co-expressing the Nub-fusion proteins and hSkp1-Cub-RUra3 showed weak uracil 
auxotrophy, and 5-FOA resistance. This meant that the six candidates interacted with 
hSkp1. However, a comparison of the strength of all the different protein pairs was 
necessary to eliminate background signals. Therefore scores ranging from 0 to 6 were 
assigned to the number of ten-fold serial dilutions for which substantial growth was 
observed on each media. This was taken as the raw score (Table 8b). The calculation for 
the average score for each pair of proteins was as listed in Section 4.7. An average 
relative score was obtained after the removing any back-ground signal by subtracting the 
Tim-Cub (Table 8a) and Nub average score. The final average score for all the protein 
pairs was listed in Table 8b as the final score. Looking at the final scores obtained, it 
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would suggest that candidates 9.1 and 13.2 did not interact with hSkp1, whereas 
candidates 7.1, 14.1 and 12.1 interacted weakly with hSkp1, and a strong interaction 
score of 2 was obtained for candidate 4.2 and hSkp1. In addition, DNA sequencing and 
BLAST results revealed the identity of the six candidates as the following: 4.2: cyclin-
dependent kinase 2-interacting protein (CINP); 7.1: putative translation initiation factor 
(SUI1); 9.1: hypothetical protein FLJ14346; 13.2: S100 calcium binding protein A6 
(calcyclin) and 14.1: S100 calcium binding protein A11 (calgizzarin) (Table 9). 
Incidentally, candidate 12.1 was identified as cyclin-dependent kinase 2-interacting 
protein (CINP) identical to candidate 4.2, but the sequences in the 3’untranlsated region 
for both plasmids were different. This difference may have affected the stability of the 
construct, resulting in different protein levels (Figure 20). The differences in interaction 
with hSkp1-Cub-RUra3 and Tim-Cub-RUra3 between candidate 4.2 and 12.1 could also be 
attributed to this reason (Figure 17, Figure 18 and Table 8a,b). 
 If the interactions which had a final score of 1 and above are taken as true 
interacting pairs, this indicates that only the Cdk2-interacting protein (CINP) was found 
from the screen to interact with hSkp1. As mentioned in Section 2.2.3.1, hSkp1 is part of 
the SCF E3 ubiquitin ligase essential for cell-cycle transition, specifically via the cyclins 
and their cyclin-dependent kinases (Cdk). CINP had been isolated in a large-scaled 
screen and analysis of human cDNA sequences (Strausberg et al., 2002), and this protein 
was recently shown to be associated with active cyclin E/Cdk2 and cyclin A/Cdk2 
complexes (Grishina and Lattes, 2005). It was proposed that CINP may be an important 
link between Cdk2 and cell division cycle gene (Cdc7) complexes at the origin of DNA 
replication. This could mean that hSkp1 may play a role in DNA replication as well. In 
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addition, as mentioned in Section 2.2.3.1, Skp1 is involved in cell-cycle progression 
where Cdk2 plays a role as well. SCFSkp2 ubiquitylates phosphorylated p27, leading to the 
activation of Cdk1 and Cdk2 at the G1-S phase transition (Sheaff et al., 1997; 
Montagnoli et al., 1999; Vlach et al., 1997). As for SCFCdc4, it targets cyclin E for 
ubiquitylation; for cyclin E to be degraded, it must first be phosphorylated by Cdk2 and 
glycogen-synthase kinase 3β (Koepp et al., 2001; Strohmaier et al., 2001). Therefore it is 
possible that CINP may play a role in cell-cycle as well since both hSkp1 and Cdk2 
regulate the mitotic cell-cycle. The next step is to use a different protein-protein 
interaction assay like co-immunoprecipitation to prove that hSkp1 and CINP are directly 
in contact and not just in close proximity. 
 Another candidate 13.2 which was identified as the S100A6 protein had been 
shown to interact with hSgt1 in vitro (Nowotny et al., 2003), and ySgt1 is known to be 
associated with ySkp1 as discussed in Section 2.2.3.3. However, no interaction between 
S100A6 and hSkp1 was documented. This protein was probably isolated because it was 
in close proximity with hSkp1 since the split-ubiquitin system is able to isolate proteins 
that are in close proximity.  
 In the Nub-cDNA library screen, no established interacting partner of hSkp1p was 
isolated. There are several reasons for this. As mentioned in Section 2.2.3.2, hSkp1 
interacts with F-box proteins is in the C-terminus helical fold region. However, the 
library screen I conducted was using a bait where the C-terminal of hSkp1p was fused to 
Cub-RUra3. The fusion of the reporter to the C-terminus of hSkp1 could result in steric 
hindrance, and decreased accessibility of interacting partners to bind to hSkp1p. 
Unfortunately, switching the fusion of hSkp1p from the N-terminus of Cub to the C-
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terminus of Cub is not feasible. This is because the ubiquitin specific proteases (Ubps) 
cleave off proteins linked to the C-terminus of ubiquitin. To overcome this problem, one 
can try to improve on the linker sequence between the two macromolecules to allow each 
protein domain to be independently functional (George and Heringa, 2003). Secondary 
structural elements that may form helical or β-sheet structures should be avoided as they 
will interfere with the flexibility of the fusion proteins, and the amino acid sequences of 
the linker could also affect the folding stability of a fusion protein (George and Heringa, 
2003). Taking these factors into consideration, I propose placing a linker sequence made 
up of small amino acids like glycines, alanines and prolines. Proline is unique among all 
the amino acids in that it cannot form hydrogen bond to any surrounding amino acids, 
therefore preventing the formation of any structure with surrounding domains. A proline 
pair is present in the current vector construct, and perhaps increasing this number may 
present interference between the two domains. Either then the C-terminal helical fold 
region, hSkp1 has also been shown to interact with Cullin 1 in the SCF complex via the 
N-terminus portion. Thus, there is a possibility that by screening a larger number of 
colonies, more clones would be covered, and therefore increasing the chances of picking 
up known interacting proteins. A different control could be also established for the 
screening of mammalian proteins using the yeast split-ubiquitin system. Currently Tim-
Cub-RUra314 has been used to show that the Nub fusion proteins interacted specifically 
with hSkp1-Cub-RUra3 and not the Cub portion. However, Tim is a yeast protein, and 
perhaps the use of a mammalian protein may be better. Alternatively, green-fluorescence 
protein (GFP) fused to Cub-RUra3 could be used as a control. 
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5.5 Conclusion 
 The interaction of full-length hSkp1p and full-length hSrb7p was observed in S. 
cerevisiae using the yeast split-ubiquitin system, and in human cells using the 
mammalian split-ubiquitin system. RNA interference to knock down hSkp1 mRNA was 
successful in reducing it by 2-fold. This reduction in hSkp1 mRNA resulted a 4-fold 
reduction of activated Hsp70B’ transcripts, indicating that hSkp1 was required for the 
efficient expression of activated Hsp70B’ transcripts. Therefore, these results suggested 
that hSkp1p could be recruited to the promoter via hSrb7p, and that it is involved in 
transcription. A cDNA library was cloned for the study of protein-protein interactions 
using the yeast-split ubiquitin system. A screen for interacting partners of hSkp1p was 
performed in hope of finding interacting partners that would help us in understanding the 
functions of hSkp1p. Cyclin-dependent kinase 2-interacting protein (CINP) was isolated 
as in interacting partner of hSkp1p. 
 
5.6 Future work 
 The interaction of hSrb7p and hSkp1p was observed in mammalian cells, and I 
think it would be interesting to find out the sequences in hSrb7 that mediate the binding 
of these two proteins. This is because hSkp1p is known to bind to F-box proteins that as 
their name implied, carry an F-box sequence domain. Although it is highly unlikely that 
hSrb7p possesses such a protein motif, the discovery of the exact sequences to which 
hSkp1p binds to may allow us to identify other candidates that hSkp1p may interact with. 
In addition, the N-terminus of Srb7p is well conserved in species like S. cerevisiae, 
Drosophila melanogaster and Homo sapiens. Should the interaction domain be in this 
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region, there is a high probability that similar interacting protein pair would also be found 
in the organisms mentioned above. 
 If the interaction of hSrb7p and hSkp1p recruits the SCF ubiquitin ligase activity, 
which protein is the target of this complex to be poly-ubiquitylated and degraded? What 
role does hSkp1p play in transcriptional initiation and possibly transcription elongation? 
These answers to these questions remain to be discovered. I have proposed several 
experiments to investigate the functions of hSkp1p and hSrb7p.  
 In D. melanogaster, the Mediator complex has been shown to be rapidly recruited 
to the heat shock promoter upon heat shock (Park et al., 2001), and this includes Srb7p as 
well. Therefore, if we assume that hSrb7p would also be recruited to the human heat 
shock promoter upon heat shock, this suggests that hSkp1p could be recruited via hSrb7p. 
The use of chromatin immunoprecipitation (Ch-IP) assay would definitely be useful in 
this aspect to examine if both proteins are found at the HSP loci and are dependent on 
heat-shock stimulus. In addition, RNA interference to knock down hSrb7 mRNA could 
also be coupled with the Ch-IP experiment to observe if the reduction in hSrb7 has any 
effects on the recruitment of hSkp1p to the promoter.  
 In addition, the use of RNA interference to reduce the mRNA of hSrb7 and 
examine how this affects the Hsp70B’ transcripts would help us understand the role of 
hSrb7p too. I would assume that similar to that of reduction of hSkp1, the reduction in 
hSrb7 levels will result in decreased levels of activated Hsp70B’ transcripts. If this is so, 
it is an indication that these two proteins are required for the maximal activation of 
Hsp70B’. However, if the reduction in hSrb7 transcript levels results in an increase in 
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Hsp70B’ mRNA, this means that hSrb7p acts like a repressor, and exerts a different 
effect from Skp1p. 
 Since it is speculated that hSkp1p may recruit the ubiquitin ligase activity to the 
holoenzyme, resulting in the poly-ubiquitylation of a factor like a repressor and its 
degradation via the 26S proteasome, the use of proteasomal inhibitor MG132 would be 
appropriate. For instance, the reduction of hSkp1p via siRNA has resulted in a decrease 
in activated transcripts. When MG132 is added, the proteasome pathway would be 
blocked and presumably the repressor would not be degraded. Therefore one would 
observe a similar decrease in activation of transcript levels. As such this result would 
indicate that hSkp1 and the proteasome work in the same pathway. However, the use of 
MG132 proteasome inhibitor is not suitable for the Hsp70B’ gene since the addition of 
such inhibitors has an effect on basal transcription and causes an increase in production 
of heat-shocked proteins in the absence of heat-shock. Thus a different inducible system 
is required.  
 To identify the targets of the SCF ubiquitin ligase complex, I would suggest to 
look at transcription factors that are known to be phosphorylated. This is because 
phosphorylated substrate proteins like yeast Sic1p (Deshaies, 1997; Feldman et al., 1997 
and Verma et al., 1997) act as recognition signals for the SCF ubiquitin ligase complex. 
An example would be that of the activator Gcn4p which is phosphorylated by Srb10p 
after it is recruited to the holoenzyme at the promoter, and this modified form of Gcn4p is 
subsequently recognized by SCFCdc4 and degraded by the SCF complex (Irniger and 
Braus, 2003). 
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 As for the protein-protein interaction screen using hSkp1-Cub-RUra3 as bait, more 
work has to be done to further characterize the interaction between hSkp1p and the 
various candidate proteins isolated with the yeast split-ubiquitin system. For instance, in 
vitro assays should be carried out to verify the interactions since the split-ubiquitin assay 
indicates that the proteins are in close proximity, but not necessarily interacting proteins. 
For instance, one could use the glutathione-S-transferase (GST) fusion system to express 
hSkp1-GST fusion proteins and perform a GST pull-down assay. In addition, the use of 
RNA interference to reduce the levels of the genes of the isolated proteins and study the 
effects on hSkp1p would allow one to see the function of their interaction. This is 
especially the case for the cyclin-dependent kinase 2-interacting protein (CINP) isolated 
in the screen; its protein-protein interaction with Cdk2p should be tested and 
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Appendix 1: Preparation of LB with amipicillin/chloramphenicol plates (1 litre) 
• Components of the plates 
 Tryptone  10 g/L 
 Yeast Extract  5 g/L 
 Sodium chloride 5 g/L 
 
-Add 800ml of distilled water, and 0.2ml 5N sodium hydroxide to adjust the pH. 
-Mix well. Add 15 g/l Bactoagar. Autoclave, and place in 50oC water bath to cool. 





Appendix 2: Preparation of plates for culturing of yeast 
 
i. The amino acid premix* for 20L of synthetic complex media is prepared according to 
the table below: 
 
Constituent Final concentration / 20L 











Glutamic acid 2.0g 




 *To prepare plates specific amino acid, that amino acid should be excluded from 
 the mix. For instance, to prepare plates lacking tryptophan, no tryptophan would 








ii. Preparation of media 
 
 Consitution of premix   Amount used /L 
 Glucose            20g  
 Yeast Nitrogen base without amino acids         7g  
 Amino acid premix            0.7g 
 
-Add 500ml of distilled water and mix before autoclaving the media. 
-In another 1L bottle, weigh out 15g of Bactoagar, and add 500ml of distilled water 
before autoclaving it. 
-Cool the premix and agar in 55oC water bath before combing the two and pouring onto 
plates. 
-For media containing 5-FOA, add 0.85g /L. Importantly, do not autoclave the media 
containing 5-FOA. Instead heat at 55oC to dissolve the 5-FOA before filter sterilizing the 





      PP      HA tag                   RE1   Start 
    
 
Appendix 3: Sequencing results of pcDNA3-NubI2-hSkp1 plasmid using the Nub100 primer. The linker region between Nub and hSkp1 is shown followed by the 
ORF of hSkp1. PP: the proline pair inserted as part of the linker region; HA tag: haemagglutinin tag used in Western blot; RE1: this site ‘GAATTG’ came about 
due to the use of EcoRI and MunI in cloning; Start refers to the ATG start site; RE2: this site ‘GTCGAG’ came about due to the use of SalI and XhoI in cloning.  
Stop   RE2
 129
                RE1       Start  
                
 
Appendix 4: Sequencing results of pcDNA3-hSrb7-Cub-RGpt2 plasmid using the T7 promoter primer.; RE1: this site ‘GAATTG’ came about 
due to the use of EcoRI and MunI in the cloning; Start refers to the ATG start site; RE2: the XhoI site used for cloning. PP: the proline pair 
inserted as part of the linker region. 
  
RE2 PP 
